Maximus88 personal page - To The Moon

Maximus88

Maximus88

No personal profile

178Follow

2Followers

0Topic

0Badge

2021-08-04

Big Apple

Apple’s Advertising Business Is Bigger Than You Think. It Could Get Bigger Still.

2021-07-26

Uhoh

Lordstown Motors receives $400 mln investment from hedge fund

2021-07-24

Uhoh

What will Apple say about the next iPhone at earnings time? Maybe more than usual

2021-07-23

BUY

Why I’m buying the FTSE 100 now

2021-07-21

Up up up

Chembio Shares Double on $28 Million COVID Diagnostic Test Order

2021-07-20

$Cloudflare, Inc.(NET)$Wooohooo

2021-07-16

Like please!!

Microsoft stock price target raised to $310 from $285 at Mizuho

2021-07-12

Comment

Sorry, the original content has been removed

2021-07-08

Sinovac? More like novac

Indonesia, Thailand consider booster shots amid doubts over Sinovac vaccine

2021-07-07

Didi downdown

Sorry, the original content has been removed

2021-07-07

Any hope to go further?

@Zified:$Spotify Technology S.A.(SPOT)$Hmm

2021-07-06

Oh

Advaxis Jumps on Deal to Be Bought by Biosight

2021-07-04

Reject!!

Dutch Court Rejects Facebook's Offer To Dismiss Privacy Lawsuit In Netherlands

2021-07-02

Mehhhh

Why Zoom Video Stock Jumped 17% in June

2021-07-01

YES

3 Top Stocks That'll Make You Richer in July (and Beyond)

2021-07-01

So slow

@JinXiong:$ARK Innovation ETF(ARKK)$trading sideways…

2021-07-01

$ARK Innovation ETF(ARKK)$time to ??????

2021-06-29

$Walt Disney(DIS)$Not so magical after all :(

2021-06-29

Gg

Moderna’s Covid Shot Gets Regulatory Nod in India for Imports

2021-06-27

$ARK Innovation ETF(ARKK)$After all that… ?

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":"3580265488164620","uuid":"3580265488164620","gmtCreate":1617336107690,"gmtModify":1619687047753,"name":"Maximus88","pinyin":"maximus88","introduction":"","introductionEn":null,"signature":"","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":2,"headSize":178,"tweetSize":57,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"1026c425416b44e0aac28c11a0848493-2","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Senior Tiger","description":"Join the tiger community for 1000 days","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"44212b71d0be4ec88898348dbe882e03-2","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"Executive Tiger","description":"The transaction amount of the securities account reaches $300,000","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"80.89%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-1","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Elite Trader","description":"Total number of securities or futures transactions reached 30","bigImgUrl":"https://static.tigerbbs.com/ab0f87127c854ce3191a752d57b46edc","smallImgUrl":"https://static.tigerbbs.com/c9835ce48b8c8743566d344ac7a7ba8c","grayImgUrl":"https://static.tigerbbs.com/76754b53ce7a90019f132c1d2fbc698f","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"60.36%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":4,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":807127283,"gmtCreate":1628009045142,"gmtModify":1703499624000,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Big Apple&nbsp;","listText":"Big Apple&nbsp;","text":"Big Apple","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/807127283","repostId":"1171505764","repostType":4,"repost":{"id":"1171505764","pubTimestamp":1628004619,"share":"https://ttm.financial/m/news/1171505764?lang=&edition=fundamental","pubTime":"2021-08-03 23:30","market":"us","language":"en","title":"Apple’s Advertising Business Is Bigger Than You Think. It Could Get Bigger Still.","url":"https://stock-news.laohu8.com/highlight/detail?id=1171505764","media":"MarketWatch","summary":"Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted advertising.The decision has created the impression that Apple  is simply opposed to digital advertising. But that’s not actually the case. In fact, advertising is gradually becoming a material contributor to the company’s revenue base.In a research note Tuesday, Bernstein analystToni Sacconaghidoes a d","content":"<p>Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted advertising.</p>\n<p>The decision has created the impression that Apple (ticker: AAPL) is simply opposed to digital advertising. But that’s not actually the case. In fact, advertising is gradually becoming a material contributor to the company’s revenue base.</p>\n<p>In a research note Tuesday, Bernstein analystToni Sacconaghidoes a deep dive into Apple’s ad business. While the company doesn’t talk about the business much andprovides little disclosure, Sacconaghi estimates that Apple will generate about $3 billion in ad revenue in the September 2021 fiscal year, up from about $300 million in fiscal 2017. He thinks the total could grow to the $7 billion-to-$10 billion-a-year range by fiscal 2023 or 2024, boosting growth in Apple’s services business as much as three percentage points.</p>\n<p>Sacconaghi notes that most of Apple’s ad business is centered on search ads in the App Store. He says growth drivers in the business include the June addition of search ads in China, higher ad loads, and the introduction of banner ads to the store in May. He also points out that Apple generates modest revenue today—likely under $500 million a year—from ads in the Apple News and Stocks apps.</p>\n<p>There are other opportunities—including Apple Maps and Apple TV. Sacconaghi estimates that Google generates about $4 billion in ad revenue a year from Maps, with a user base about four times the size, suggesting $1 billion a year in potential ad revenue. And he says that the streaming-device companyRoku (ROKU)provides “a helpful precedent” for how Apple can generate revenue from Apple TV hardware—where he sees another $1 billion-plus opportunity.</p>\n<p>The analyst adds that Apple could place ads on other properties—like Apple Fitness+ and Garage Band—but that the adoption of advertising in applications like Apple Mail, Apple TV+, or Apple’s home screens likely would “irk consumers and undermine Apple’s strongly avowed stance on privacy.”</p>\n<p>Meanwhile, Sacconaghi says, Apple’s position on Identifier for Advertisers, or IDFA, offers the company some competitive advantages. “While we believe that Apple’s move to eliminate IDFA was done in the spirit of advancing consumer privacy, it may ultimately provide Apple with an advertising platform that is competitively advantaged vs. peers who don’t have access to Apple’s richer APIs,” he writes.</p>\n<p>The analyst notes thatAmazon.com‘s (AMZN) ad business was similar in size to Apple’s in 2017—and now has a run rate north of $25 billion and is a substantial part of the investment thesis on the stock. “Along similar lines, a large and growing advertising business could help Apple accelerate its overall Services growth rate, which would likely be viewed positively by investors,” he concludes.</p>\n<p>Apple shares were up 0.1%, at $145.72, in recent trading. TheS&amp;P 500was down fractionally.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple’s Advertising Business Is Bigger Than You Think. It Could Get Bigger Still.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple’s Advertising Business Is Bigger Than You Think. It Could Get Bigger Still.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-03 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/apples-advertising-business-is-bigger-than-you-think-it-could-get-bigger-still-51628004419?mod=mw_latestnews><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/apples-advertising-business-is-bigger-than-you-think-it-could-get-bigger-still-51628004419?mod=mw_latestnews\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.marketwatch.com/articles/apples-advertising-business-is-bigger-than-you-think-it-could-get-bigger-still-51628004419?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1171505764","content_text":"Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted advertising.\nThe decision has created the impression that Apple (ticker: AAPL) is simply opposed to digital advertising. But that’s not actually the case. In fact, advertising is gradually becoming a material contributor to the company’s revenue base.\nIn a research note Tuesday, Bernstein analystToni Sacconaghidoes a deep dive into Apple’s ad business. While the company doesn’t talk about the business much andprovides little disclosure, Sacconaghi estimates that Apple will generate about $3 billion in ad revenue in the September 2021 fiscal year, up from about $300 million in fiscal 2017. He thinks the total could grow to the $7 billion-to-$10 billion-a-year range by fiscal 2023 or 2024, boosting growth in Apple’s services business as much as three percentage points.\nSacconaghi notes that most of Apple’s ad business is centered on search ads in the App Store. He says growth drivers in the business include the June addition of search ads in China, higher ad loads, and the introduction of banner ads to the store in May. He also points out that Apple generates modest revenue today—likely under $500 million a year—from ads in the Apple News and Stocks apps.\nThere are other opportunities—including Apple Maps and Apple TV. Sacconaghi estimates that Google generates about $4 billion in ad revenue a year from Maps, with a user base about four times the size, suggesting $1 billion a year in potential ad revenue. And he says that the streaming-device companyRoku (ROKU)provides “a helpful precedent” for how Apple can generate revenue from Apple TV hardware—where he sees another $1 billion-plus opportunity.\nThe analyst adds that Apple could place ads on other properties—like Apple Fitness+ and Garage Band—but that the adoption of advertising in applications like Apple Mail, Apple TV+, or Apple’s home screens likely would “irk consumers and undermine Apple’s strongly avowed stance on privacy.”\nMeanwhile, Sacconaghi says, Apple’s position on Identifier for Advertisers, or IDFA, offers the company some competitive advantages. “While we believe that Apple’s move to eliminate IDFA was done in the spirit of advancing consumer privacy, it may ultimately provide Apple with an advertising platform that is competitively advantaged vs. peers who don’t have access to Apple’s richer APIs,” he writes.\nThe analyst notes thatAmazon.com‘s (AMZN) ad business was similar in size to Apple’s in 2017—and now has a run rate north of $25 billion and is a substantial part of the investment thesis on the stock. “Along similar lines, a large and growing advertising business could help Apple accelerate its overall Services growth rate, which would likely be viewed positively by investors,” he concludes.\nApple shares were up 0.1%, at $145.72, in recent trading. TheS&P 500was down fractionally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800415227,"gmtCreate":1627312055269,"gmtModify":1703487458046,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Uhoh","listText":"Uhoh","text":"Uhoh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800415227","repostId":"1143156640","repostType":4,"repost":{"id":"1143156640","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1627308345,"share":"https://ttm.financial/m/news/1143156640?lang=&edition=fundamental","pubTime":"2021-07-26 22:05","market":"us","language":"en","title":"Lordstown Motors receives $400 mln investment from hedge fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1143156640","media":"Reuters","summary":"July 26 (Reuters) - Lordstown Motors Corp(RIDE.O)said on Monday it received a $400 million equity in","content":"<p>July 26 (Reuters) - Lordstown Motors Corp(RIDE.O)said on Monday it received a $400 million equity investment from hedge fund YA II PN Ltd, at a time when the electric-truck maker is under regulatory scrutiny related to its SPAC merger and vehicle pre-orders.</p>\n<p>According to a regulatoryfiling, Mountainside, New Jersey-based fund YA, managed by investment management services provider Yorkville Advisors Global LP, has agreed not to engage in any short sales or hedging transactions on Lordstown stock.</p>\n<p>Yorkville Advisors Global did not immediately respond to a Reuters' request for comment.</p>\n<p>The company's shares were up 4.3% at $7.8, and are on track to snap a three-day streak of losses.</p>\n<p>Lordstown said last week federal prosecutors in Manhattan were investigating its vehicle pre-orders and its merger with blank-check company DiamondPeak Holdings.</p>\n<p><img src=\"https://static.tigerbbs.com/647b43181c74fd35ee0017a484a51311\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lordstown Motors receives $400 mln investment from hedge fund</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLordstown Motors receives $400 mln investment from hedge fund\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-26 22:05</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>July 26 (Reuters) - Lordstown Motors Corp(RIDE.O)said on Monday it received a $400 million equity investment from hedge fund YA II PN Ltd, at a time when the electric-truck maker is under regulatory scrutiny related to its SPAC merger and vehicle pre-orders.</p>\n<p>According to a regulatoryfiling, Mountainside, New Jersey-based fund YA, managed by investment management services provider Yorkville Advisors Global LP, has agreed not to engage in any short sales or hedging transactions on Lordstown stock.</p>\n<p>Yorkville Advisors Global did not immediately respond to a Reuters' request for comment.</p>\n<p>The company's shares were up 4.3% at $7.8, and are on track to snap a three-day streak of losses.</p>\n<p>Lordstown said last week federal prosecutors in Manhattan were investigating its vehicle pre-orders and its merger with blank-check company DiamondPeak Holdings.</p>\n<p><img src=\"https://static.tigerbbs.com/647b43181c74fd35ee0017a484a51311\" tg-width=\"840\" tg-height=\"470\" width=\"100%\" height=\"auto\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143156640","content_text":"July 26 (Reuters) - Lordstown Motors Corp(RIDE.O)said on Monday it received a $400 million equity investment from hedge fund YA II PN Ltd, at a time when the electric-truck maker is under regulatory scrutiny related to its SPAC merger and vehicle pre-orders.\nAccording to a regulatoryfiling, Mountainside, New Jersey-based fund YA, managed by investment management services provider Yorkville Advisors Global LP, has agreed not to engage in any short sales or hedging transactions on Lordstown stock.\nYorkville Advisors Global did not immediately respond to a Reuters' request for comment.\nThe company's shares were up 4.3% at $7.8, and are on track to snap a three-day streak of losses.\nLordstown said last week federal prosecutors in Manhattan were investigating its vehicle pre-orders and its merger with blank-check company DiamondPeak Holdings.","news_type":1},"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174427485,"gmtCreate":1627130218547,"gmtModify":1703484628900,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Uhoh","listText":"Uhoh","text":"Uhoh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/174427485","repostId":"2153938547","repostType":4,"repost":{"id":"2153938547","pubTimestamp":1627085070,"share":"https://ttm.financial/m/news/2153938547?lang=&edition=fundamental","pubTime":"2021-07-24 08:04","market":"us","language":"en","title":"What will Apple say about the next iPhone at earnings time? Maybe more than usual","url":"https://stock-news.laohu8.com/highlight/detail?id=2153938547","media":"MarketWatch","summary":"Apple earnings preview: Recent lack of quarterly forecasts could lead executives to divulge a few mo","content":"<p>Apple earnings preview: Recent lack of quarterly forecasts could lead executives to divulge a few more hints about the next iPhone release when discussing results Tuesday afternoon</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/1694f71fa4dec194ef63e28ffc75776f\" tg-width=\"700\" tg-height=\"495\" width=\"100%\" height=\"auto\"><span>Heavy promotions in the wireless industry likely benefited Apple's business during the June quarter.</span></p>\n<p>The pandemic may add a wrinkle to the guessing game that normally accompanies Apple Inc.'s June-quarter conference call.</p>\n<p>Typically the most important tidbit coming out of fiscal third-quarter earnings, which Apple <a href=\"https://laohu8.com/S/AAPL\">$(AAPL)$</a> is scheduled to report Tuesday afternoon, is the company's outlook and commentary around its September-quarter revenue, which can hold clues as to what the company expects in the early days of its next smartphone launch. A strong forecast may imply that the company intends to make its new lineup available during the waning days of its fiscal year, while weaker guidance could suggest the launch will be pushed in to the calendar fourth quarter.</p>\n<p>The problem this time around is that Apple has held off on issuing a formal outlook for more than a year amid the pandemic, and it remains unclear when or if the company will resume the practice. Apple has instead been offering \"directional insights\" to offer some indication of how its results could stack up to those of prior quarters, but it has been notoriously tight-lipped about plans for iPhone launches.</p>\n<p>\"We expect the timing of iPhone 13 availability will ultimately prove to be the swing factor in [the fiscal fourth quarter], thus we anticipate the company will provide more granular directional commentary,\" wrote Monness, Crespi, Hardt &amp; Co. analyst Brian White.</p>\n<p>The coming launch is of keen interest given that the current lineup has performed well. \"The iPhone 12 cycle has been strong but we believe the next two cycles may prove challenging with units potentially down [year over year] in FY22 and FY23,\" wrote Barclays analyst Tim Long.</p>\n<p>The June quarter that Apple will report Tuesday is traditionally a slower <a href=\"https://laohu8.com/S/AONE.U\">one</a>, as consumers wait for the next iPhone launch, but the company is still expected to deliver big growth in its smartphone business. Not only does the company have the benefit of easy comparisons to the early days of the pandemic, but it should also be reaping the rewards of an unusually promotional wireless industry.</p>\n<p><b>What to watch for</b></p>\n<p><b>Earnings:</b> Analysts tracked by FactSet expect Apple to post $1.01 in earnings per share, up from 65 cents a year earlier. According to Estimize, which crowdsources projections from hedge funds, academics, and others, the average expectation is for $1.16 a share in EPS.</p>\n<p><b>Revenue: </b>The FactSet consensus calls for $73.26 billion in overall revenue, up from $59.69 billion a year prior. On Estimize, the average estimate is for $77.38 billion.</p>\n<p>On a segment level, analysts surveyed by FactSet project $34.19 billion in iPhone revenue, $7.17 billion in iPad revenue, $7.86 billion in Mac revenue, $16.26 billion in services revenue, and $7.83 billion in revenue for the wearables, home, and accessories category.</p>\n<p><b>Stock movement: </b>Apple shares have fallen after four of the past five earnings reports, though the stock is up 60% over the past 12 months as the Dow Jones Industrial Average has increased 32%.</p>\n<p>Of the 44 analysts tracked by FactSet who cover Apple's stock, 33 have buy ratings, nine have hold ratings and two have sell ratings, with an average price target of $157.88.</p>\n<p><b>What else to watch for</b></p>\n<p>Apple's iPhone business is set up for its second-largest rate of growth in at least three years, behind only what was seen in the previous quarter. Analysts tracked by FactSet are calling for $34.2 billion in iPhone revenue, up 29.4% from a year earlier.</p>\n<p>Some encouraging signals came from Verizon Communications Inc. <a href=\"https://laohu8.com/S/VZ\">$(VZ)$</a>, which recently ran a big iPhone promotion as it sought to match discounts at rival AT&amp;T Inc. <a href=\"https://laohu8.com/S/T\">$(T)$</a></p>\n<p>\"Momentum built throughout the quarter, and we timed our promotions to take full advantage of the economic recovery and increased customer activity,\" Verizon Chief Financial Officer Matthew Ellis said on his company's earnings call. About 20% of Verizon's consumer base is now using 5G-enabled phones .</p>\n<p>Raymond James analyst Chris Caso noted that the quantity of upgrades might not even be the most important factor, as his analysis of iPhone carrier deals from last year found that they can be helpful in driving a greater \"mix\" of more expensive devices.</p>\n<p>\"Consumers appear to have been willing to pay the few dollars per month to upgrade to higher-end models, if the base model was offered for free,\" he wrote, based on analyzing last year's subsidies.</p>\n<p>UBS analyst David Vogt is also feeling upbeat about the business heading into the fiscal third-quarter report, pointing to positive signs in the telecommunications industry like the \"aggressive promotions\" and improving retail traffic at wireless stores.</p>\n<p>But he notes that demand may not be the big issue for Apple, as the company's overall upside is \"gated\" due to supply constraints plaguing the broader electronics industry and beyond. Apple addressed these issues on its earnings call, projecting a $3 billion to $4 billion negative revenue impact in the June quarter that was mainly expected to affect the Mac and iPad businesses.</p>\n<p>Another key narrative is how those two segments held up more generally given a return to more normalized activities outside the home. Apple's Macs and iPads were popular purchases among those needing new hardware to power remote working and schooling, but analysts will be looking to see whether the personal-computer boom is sustainable.</p>\n<p>\"While Apple will have to contend with lapping very difficult pandemic comparisons in the [June quarter] and for several quarters thereafter, we see several near-term tailwinds from both categories,\" wrote CFRA analyst Angelo Zino. \"We see corporate upgrades on the enterprise level becoming a bigger contributor to demand as the economy fully reopens across the globe.\"</p>\n<p>The coming results will also be the first gauge on demand for Apple's new colorful iMac lineup and powerful iPad Pro , both of which rolled out in the spring and feature the company's custom M1 chip.</p>","source":"lsy1603348471595","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>What will Apple say about the next iPhone at earnings time? Maybe more than usual</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhat will Apple say about the next iPhone at earnings time? Maybe more than usual\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-24 08:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/what-will-apple-say-about-the-next-iphone-at-earnings-time-maybe-more-than-usual-11627077819?mod=home-page><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple earnings preview: Recent lack of quarterly forecasts could lead executives to divulge a few more hints about the next iPhone release when discussing results Tuesday afternoon\nHeavy promotions in...</p>\n\n<a href=\"https://www.marketwatch.com/story/what-will-apple-say-about-the-next-iphone-at-earnings-time-maybe-more-than-usual-11627077819?mod=home-page\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.marketwatch.com/story/what-will-apple-say-about-the-next-iphone-at-earnings-time-maybe-more-than-usual-11627077819?mod=home-page","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2153938547","content_text":"Apple earnings preview: Recent lack of quarterly forecasts could lead executives to divulge a few more hints about the next iPhone release when discussing results Tuesday afternoon\nHeavy promotions in the wireless industry likely benefited Apple's business during the June quarter.\nThe pandemic may add a wrinkle to the guessing game that normally accompanies Apple Inc.'s June-quarter conference call.\nTypically the most important tidbit coming out of fiscal third-quarter earnings, which Apple $(AAPL)$ is scheduled to report Tuesday afternoon, is the company's outlook and commentary around its September-quarter revenue, which can hold clues as to what the company expects in the early days of its next smartphone launch. A strong forecast may imply that the company intends to make its new lineup available during the waning days of its fiscal year, while weaker guidance could suggest the launch will be pushed in to the calendar fourth quarter.\nThe problem this time around is that Apple has held off on issuing a formal outlook for more than a year amid the pandemic, and it remains unclear when or if the company will resume the practice. Apple has instead been offering \"directional insights\" to offer some indication of how its results could stack up to those of prior quarters, but it has been notoriously tight-lipped about plans for iPhone launches.\n\"We expect the timing of iPhone 13 availability will ultimately prove to be the swing factor in [the fiscal fourth quarter], thus we anticipate the company will provide more granular directional commentary,\" wrote Monness, Crespi, Hardt & Co. analyst Brian White.\nThe coming launch is of keen interest given that the current lineup has performed well. \"The iPhone 12 cycle has been strong but we believe the next two cycles may prove challenging with units potentially down [year over year] in FY22 and FY23,\" wrote Barclays analyst Tim Long.\nThe June quarter that Apple will report Tuesday is traditionally a slower one, as consumers wait for the next iPhone launch, but the company is still expected to deliver big growth in its smartphone business. Not only does the company have the benefit of easy comparisons to the early days of the pandemic, but it should also be reaping the rewards of an unusually promotional wireless industry.\nWhat to watch for\nEarnings: Analysts tracked by FactSet expect Apple to post $1.01 in earnings per share, up from 65 cents a year earlier. According to Estimize, which crowdsources projections from hedge funds, academics, and others, the average expectation is for $1.16 a share in EPS.\nRevenue: The FactSet consensus calls for $73.26 billion in overall revenue, up from $59.69 billion a year prior. On Estimize, the average estimate is for $77.38 billion.\nOn a segment level, analysts surveyed by FactSet project $34.19 billion in iPhone revenue, $7.17 billion in iPad revenue, $7.86 billion in Mac revenue, $16.26 billion in services revenue, and $7.83 billion in revenue for the wearables, home, and accessories category.\nStock movement: Apple shares have fallen after four of the past five earnings reports, though the stock is up 60% over the past 12 months as the Dow Jones Industrial Average has increased 32%.\nOf the 44 analysts tracked by FactSet who cover Apple's stock, 33 have buy ratings, nine have hold ratings and two have sell ratings, with an average price target of $157.88.\nWhat else to watch for\nApple's iPhone business is set up for its second-largest rate of growth in at least three years, behind only what was seen in the previous quarter. Analysts tracked by FactSet are calling for $34.2 billion in iPhone revenue, up 29.4% from a year earlier.\nSome encouraging signals came from Verizon Communications Inc. $(VZ)$, which recently ran a big iPhone promotion as it sought to match discounts at rival AT&T Inc. $(T)$\n\"Momentum built throughout the quarter, and we timed our promotions to take full advantage of the economic recovery and increased customer activity,\" Verizon Chief Financial Officer Matthew Ellis said on his company's earnings call. About 20% of Verizon's consumer base is now using 5G-enabled phones .\nRaymond James analyst Chris Caso noted that the quantity of upgrades might not even be the most important factor, as his analysis of iPhone carrier deals from last year found that they can be helpful in driving a greater \"mix\" of more expensive devices.\n\"Consumers appear to have been willing to pay the few dollars per month to upgrade to higher-end models, if the base model was offered for free,\" he wrote, based on analyzing last year's subsidies.\nUBS analyst David Vogt is also feeling upbeat about the business heading into the fiscal third-quarter report, pointing to positive signs in the telecommunications industry like the \"aggressive promotions\" and improving retail traffic at wireless stores.\nBut he notes that demand may not be the big issue for Apple, as the company's overall upside is \"gated\" due to supply constraints plaguing the broader electronics industry and beyond. Apple addressed these issues on its earnings call, projecting a $3 billion to $4 billion negative revenue impact in the June quarter that was mainly expected to affect the Mac and iPad businesses.\nAnother key narrative is how those two segments held up more generally given a return to more normalized activities outside the home. Apple's Macs and iPads were popular purchases among those needing new hardware to power remote working and schooling, but analysts will be looking to see whether the personal-computer boom is sustainable.\n\"While Apple will have to contend with lapping very difficult pandemic comparisons in the [June quarter] and for several quarters thereafter, we see several near-term tailwinds from both categories,\" wrote CFRA analyst Angelo Zino. \"We see corporate upgrades on the enterprise level becoming a bigger contributor to demand as the economy fully reopens across the globe.\"\nThe coming results will also be the first gauge on demand for Apple's new colorful iMac lineup and powerful iPad Pro , both of which rolled out in the spring and feature the company's custom M1 chip.","news_type":1},"isVote":1,"tweetType":1,"viewCount":569,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":175546793,"gmtCreate":1627044174912,"gmtModify":1703483100471,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"BUY","listText":"BUY","text":"BUY","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175546793","repostId":"1175079456","repostType":4,"repost":{"id":"1175079456","pubTimestamp":1627036648,"share":"https://ttm.financial/m/news/1175079456?lang=&edition=fundamental","pubTime":"2021-07-23 18:37","market":"uk","language":"en","title":"Why I’m buying the FTSE 100 now","url":"https://stock-news.laohu8.com/highlight/detail?id=1175079456","media":"The Motley Fool","summary":"According to IG, between 1984 and 2019, the FTSE 100 rose by 654%. And on a total return basis, the ","content":"<p>According to&nbsp;<b>IG</b>, between 1984 and 2019, the&nbsp;<a href=\"https://laohu8.com/S/.UKX.UK\">FTSE 100</a>&nbsp;rose by 654%. And on a total return basis, the value increased by 1,377%. &nbsp;Annualising the figures reveals the yearly return for investors over the period was 5.8%, and 7.8% with dividends reinvested.</p>\n<p>And that’s why one of the long-term investments in my portfolio is a&nbsp;FTSE 100 tracker fund. And, naturally, I’m holding the accumulation version of the fund rather than the income version so that the dividends are automatically reinvested.</p>\n<p><b>Handling the FTSE 100’s volatility</b></p>\n<p>But what’s the best course of action in uncertain times like now when the index is so volatile? For me, there’s only one answer — keep investing. So my monthly contributions will keep dripping into the <a href=\"https://laohu8.com/S/.UKX.UK\">FTSE 100</a> tracker fund however low the index happens to fall.</p>\n<p>And in behaving like that I’m following the advice of perhaps the greatest investor of them all, Warren Buffett. In an interview in February 2020, when the stock market was crashing because of coronavirus, he repeated his long-held view. When asked about falling stock prices, he said:&nbsp;<i>“That’s good for us actually. We’re a net buyer of stocks over time.”</i></p>\n<p>Isn’t that a bit odd though? Surely if we buy stocks and make investments into tracker funds we then want them to go up in price to provide us with a positive return. And, of course, that’s true over the long term. But Buffett has always had an ear to the ground for a bargain. Buying the shares of good businesses at fair valuations is a strategy that’s made him billions.</p>\n<p>He expanded the point in the CNBC interview, saying:<i>“[It’s] just like being a net buyer of food — I expect to buy food for the rest of my life and I hope that food goes down in price tomorrow.”</i></p>\n<p>And the approach works with my <a href=\"https://laohu8.com/S/.UKX.UK\">FTSE 100</a> tracker investment as well. If the index falls, my fixed monthly investment buys more. But, over the long haul, the returns from my investment could be worth the short-term ‘pain’ of lower prices.</p>\n<p><b>There’s always something to worry about</b></p>\n<p>Meanwhile, there’s rarely a relaxed and rosy picture to look at from the perspective of being an investor. It seems like there’s always something to worry about, if worry I must. Right now, the anxieties of the day include coronavirus, inflation, asset bubbles and other things. But I reckon the key to capturing the bigger, long-term returns potentially available from the FTSE 100 is to keep up my regular investments, no matter what happens to the index.</p>\n<p>Of course, there’s no guarantee the <a href=\"https://laohu8.com/S/.UKX.UK\">FTSE 100</a> will deliver returns as large as it has before. Perhaps the first 35 years of its life were an exceptional period. And my plan could fall flat if I end up cutting my investment horizon short. Over perhaps five years or so, I could easily lose money overall.</p>\n<p>But as a long-term strategy, I’m sticking with it no matter what the Footsie does next.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why I’m buying the FTSE 100 now</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy I’m buying the FTSE 100 now\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 18:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.co.uk/investing/2021/07/23/why-im-buying-the-ftse-100-now/><strong>The Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>According to IG, between 1984 and 2019, the FTSE 100 rose by 654%. And on a total return basis, the value increased by 1,377%.  Annualising the figures reveals the yearly return for investors over the...</p>\n\n<a href=\"https://www.fool.co.uk/investing/2021/07/23/why-im-buying-the-ftse-100-now/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".UKX.UK":"富时100指数"},"source_url":"https://www.fool.co.uk/investing/2021/07/23/why-im-buying-the-ftse-100-now/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175079456","content_text":"According to IG, between 1984 and 2019, the FTSE 100 rose by 654%. And on a total return basis, the value increased by 1,377%.  Annualising the figures reveals the yearly return for investors over the period was 5.8%, and 7.8% with dividends reinvested.\nAnd that’s why one of the long-term investments in my portfolio is a FTSE 100 tracker fund. And, naturally, I’m holding the accumulation version of the fund rather than the income version so that the dividends are automatically reinvested.\nHandling the FTSE 100’s volatility\nBut what’s the best course of action in uncertain times like now when the index is so volatile? For me, there’s only one answer — keep investing. So my monthly contributions will keep dripping into the FTSE 100 tracker fund however low the index happens to fall.\nAnd in behaving like that I’m following the advice of perhaps the greatest investor of them all, Warren Buffett. In an interview in February 2020, when the stock market was crashing because of coronavirus, he repeated his long-held view. When asked about falling stock prices, he said: “That’s good for us actually. We’re a net buyer of stocks over time.”\nIsn’t that a bit odd though? Surely if we buy stocks and make investments into tracker funds we then want them to go up in price to provide us with a positive return. And, of course, that’s true over the long term. But Buffett has always had an ear to the ground for a bargain. Buying the shares of good businesses at fair valuations is a strategy that’s made him billions.\nHe expanded the point in the CNBC interview, saying:“[It’s] just like being a net buyer of food — I expect to buy food for the rest of my life and I hope that food goes down in price tomorrow.”\nAnd the approach works with my FTSE 100 tracker investment as well. If the index falls, my fixed monthly investment buys more. But, over the long haul, the returns from my investment could be worth the short-term ‘pain’ of lower prices.\nThere’s always something to worry about\nMeanwhile, there’s rarely a relaxed and rosy picture to look at from the perspective of being an investor. It seems like there’s always something to worry about, if worry I must. Right now, the anxieties of the day include coronavirus, inflation, asset bubbles and other things. But I reckon the key to capturing the bigger, long-term returns potentially available from the FTSE 100 is to keep up my regular investments, no matter what happens to the index.\nOf course, there’s no guarantee the FTSE 100 will deliver returns as large as it has before. Perhaps the first 35 years of its life were an exceptional period. And my plan could fall flat if I end up cutting my investment horizon short. Over perhaps five years or so, I could easily lose money overall.\nBut as a long-term strategy, I’m sticking with it no matter what the Footsie does next.","news_type":1},"isVote":1,"tweetType":1,"viewCount":432,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176895910,"gmtCreate":1626875307930,"gmtModify":1703479722981,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176895910","repostId":"1139204971","repostType":4,"repost":{"id":"1139204971","pubTimestamp":1626873342,"share":"https://ttm.financial/m/news/1139204971?lang=&edition=fundamental","pubTime":"2021-07-21 21:15","market":"us","language":"en","title":"Chembio Shares Double on $28 Million COVID Diagnostic Test Order","url":"https://stock-news.laohu8.com/highlight/detail?id=1139204971","media":"The Street","summary":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostic","content":"<blockquote>\n Chembio will provide 20-minute nasal swab test to a company in Brazil.\n</blockquote>\n<p>Shares of <a href=\"https://laohu8.com/S/CEMI\">Chembio Diagnostics</a>&nbsp;(<b>CEMI</b>) -Get Report&nbsp;doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.</p>\n<p>The test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.</p>\n<p>“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.</p>\n<p>Shares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.</p>\n<p>\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.</p>\n<p>Chembio is a point-of-care diagnostic company focused on infectious diseases.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Chembio Shares Double on $28 Million COVID Diagnostic Test Order</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nChembio Shares Double on $28 Million COVID Diagnostic Test Order\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-21 21:15 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 ...</p>\n\n<a href=\"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"CEMI":"Chembio Diagnostics"},"source_url":"https://www.thestreet.com/investing/chembio-diagnostics-cemi-covid-test-order","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1139204971","content_text":"Chembio will provide 20-minute nasal swab test to a company in Brazil.\n\nShares of Chembio Diagnostics (CEMI) -Get Report doubled in premarket trading Wednesday after the company received a $28.3 million purchase order from Bio-Manguinhos for SARS-CoV-2 Antigen tests in Brazil.\nThe test is designed to detect the COVID-19 pathogen in only 20 minutes using a \"minimally invasive\" nasal swab.\n“We are pleased to significantly expand our customer relationship with Bio-Manguinhos to address the testing needs surrounding COVID-19,” said Javan Esfandiari, Chembio’s executive vice president, chief science and technology officer.\nShares of Chembio Diagnostics jumped 100.49% to $4.13 early Wednesday.\n\"We believe the purchase order validates the investments we made earlier this year in inventory for the DPP SARS-CoV-2 Antigen test and look forward to ramping up production,\" Esfandiari said.\nChembio is a point-of-care diagnostic company focused on infectious diseases.","news_type":1},"isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":171733993,"gmtCreate":1626762866112,"gmtModify":1703764726723,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/NET\">$Cloudflare, Inc.(NET)$</a>Wooohooo","listText":"<a href=\"https://laohu8.com/S/NET\">$Cloudflare, Inc.(NET)$</a>Wooohooo","text":"$Cloudflare, Inc.(NET)$Wooohooo","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/171733993","isVote":1,"tweetType":1,"viewCount":538,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":170211047,"gmtCreate":1626434977389,"gmtModify":1703760095587,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Like please!!","listText":"Like please!!","text":"Like please!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/170211047","repostId":"2151509460","repostType":4,"repost":{"id":"2151509460","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1626432720,"share":"https://ttm.financial/m/news/2151509460?lang=&edition=fundamental","pubTime":"2021-07-16 18:52","market":"us","language":"en","title":"Microsoft stock price target raised to $310 from $285 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2151509460","media":"Dow Jones","summary":"Microsoft stock price target raised to $310 from $285 at Mizuho","content":"<p>Microsoft stock price target raised to $310 from $285 at Mizuho</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Microsoft stock price target raised to $310 from $285 at Mizuho</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicrosoft stock price target raised to $310 from $285 at Mizuho\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-07-16 18:52</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Microsoft stock price target raised to $310 from $285 at Mizuho</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MSFT":"微软"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2151509460","content_text":"Microsoft stock price target raised to $310 from $285 at Mizuho","news_type":1},"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146570310,"gmtCreate":1626093876430,"gmtModify":1703753189337,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/146570310","repostId":"2150535792","repostType":4,"isVote":1,"tweetType":1,"viewCount":647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":149409096,"gmtCreate":1625739964015,"gmtModify":1703747502030,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Sinovac? More like novac","listText":"Sinovac? More like novac","text":"Sinovac? More like novac","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/149409096","repostId":"2149434973","repostType":2,"repost":{"id":"2149434973","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1625738506,"share":"https://ttm.financial/m/news/2149434973?lang=&edition=fundamental","pubTime":"2021-07-08 18:01","market":"us","language":"en","title":"Indonesia, Thailand consider booster shots amid doubts over Sinovac vaccine","url":"https://stock-news.laohu8.com/highlight/detail?id=2149434973","media":"Reuters","summary":"By Chayut Setboonsarng and Stanley Widianto   BANGKOK/JAKARTA, July 8 (Reuters) - Indonesia and Thai","content":"<html><body><p>By Chayut Setboonsarng and Stanley Widianto</p><p>   BANGKOK/JAKARTA, July 8 (Reuters) - Indonesia and Thailand are considering offering a booster shot to their medical workers immunized with Sinovac's COVID-19 vaccine, a move likely to reduce public trust in the Chinese product that has been their main inoculation tool.    </p><p>   Some countries including Turkey and the United Arab Emirates</p><p>have already started giving a booster shot to those inoculated with Chinese vaccines amid concerns that they may not be as effective against new and more transmissible coronavirus variants.  </p><p>   But the challenges facing Southeast Asia are much bigger. Many countries in the region rely heavily on Chinese vaccines due to tight supplies of Western products, and have low vaccination rates of less than 10%.</p><p>   They are also battling a record-breaking surge in new cases and deaths, led by the highly contagious Delta variant, while rising infections among medical workers despite being fully immunised with the Sinovac    shots have stretched already thin healthcare systems.</p><p>   \"There's a lot of doctors and medical workers who have been vaccinated twice but endured medium and severe symptoms, or even died,\" Slamet Budiarto, deputy chief of the Indonesian Medical Association, told parliament on Monday.</p><p>   Indonesia has vaccinated millions of its healthcare workers with the Sinovac shot and thousands of them are now testing positive for COVID-19.   </p><p>   \"It is the time for medical workers to get a third booster to protect them from the impact of more vicious and worrying new variants,\" said Melki Laka Lena, deputy chairman of the parliamentary commission overseeing health. </p><p>   Siti Nadia Tarmizi, an official from Indonesia's health ministry, said it is waiting for recommendations from immunization advisory group and Indonesia's Food and Drug Agency (BPOM) about the use of a booster shot.</p><p>   While some real world data showed the Sinovac vaccine is effective against hospitalisation and severe COVID-19 cases, there is no detailed data yet on its effectiveness against the Delta variant, first identified in India. </p><p>   Thailand, which expects to receive a donation of 1.5 million Pfizer-BioNtech     shots from the United States later this month, plans to use it in inoculating its 700,000 medical workers, most of whom have already received two shots of Sinovac. </p><p>   Senior health official Udom Kachintorn said the plan was aimed at increasing immunity, as the Delta variant increases case loads and scores of medical workers who had been fully vaccinated with the Sinovac became infected.</p><p>   A leaked Thai health ministry document this week showed that the government was concerned about such a move sending a wrong signal to the public because it would be admitting that the Sinovac vaccine was not effective.  </p><p>   \"It will definitely have an impact on the trust in the vaccine,\" said Dicky Budiman, an epidemiologist at Australia's Griffith University.</p><p>   \"The vaccine isn't necessarily ineffective, but its efficacy slides down after six months. That's my prediction,\" he said, recommending authorities consider a booster shot as a solution and communicate the problems with the public.</p><p>   Thai authorities have defended the vaccine's use and its plan to purchase more Sinovac vaccines. </p><p>   \"Don't downgrade Sinovac even though we know efficacy is lower. It reduces the number of patients with critical condition, and fatalities,\" Udom said. </p><p>   Indonesian doctors also acknowledge that Sinovac might not be the best vaccine on the market, but say that for now that is all they have, and that is better than nothing. </p><p>   \"Up to now because we cannot produce (a vaccine) we have no (other) option,\" said Eka Julianta Wahjoepramono, the dean of the medical school at Pelita Harapan University.</p><p>   \"Sinovac is the only choice,\" said Eka, who was fully vaccinated with the Sinovac but got a severe case of COVID-19 last month.    </p><p>   Sinovac did not reply to a Reuters' request for comment.</p><p>   'TIMELY RAIN' OR STILL DOUBTFUL</p><p>   Doubts about the effectiveness of Chinese vaccines threaten to undermine China's so-called \"vaccine diplomacy,\" through which Beijing has sought to increase its diplomatic influence around the world. China has shipped hundreds of millions of doses of locally developed COVID-19 shots overseas.</p><p>   Singapore said this week people who received the Sinovac shots are excluded from its count of total vaccinations due to a lack of efficacy data for the vaccine, especially against the contagious Delta variant.  </p><p>   \"We don't really have a medical or scientific basis or have the data now to establish how effective Sinovac is in terms of infection and severe illnesses on Delta,\" health minister Ong Ye Kung said.</p><p>   China reiterated that its vaccines are safe and effective.</p><p>   \"Chinese vaccines have earned a good reputation in the international community with their safety and efficacy widely recognised,\" foreign ministry spokesman Wang Wenbin said on Monday in response to a question about whether other countries have expressed concerns about Chinese vaccines. </p><p>   \"To date over 100 countries have approved Chinese vaccines... The first batch of vaccines to arrive in many developing nations are from China. They refer to the Chinese doses as 'timely rain'.\"</p><p> (Reporting by Chayut Setboonsarng and Panarat Thepgumpanat in Bangkok; Additional reporting by Karen Lema in Manila, Jonathan Spicer in Istanbul, Stanley Widanto and Agustinus Beo Da Costa in Jakarta, and Kate Lamb in Sydney, Aradhana Aravindan in Singapore and Ryan Woo in Beijing; Editing by Miyoung Kim and Kim Coghill)</p><p>((chayut.setboonsarng@tr.com, <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: @ChayutSet; +66854849033;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Indonesia, Thailand consider booster shots amid doubts over Sinovac vaccine</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIndonesia, Thailand consider booster shots amid doubts over Sinovac vaccine\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-07-08 18:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>By Chayut Setboonsarng and Stanley Widianto</p><p>   BANGKOK/JAKARTA, July 8 (Reuters) - Indonesia and Thailand are considering offering a booster shot to their medical workers immunized with Sinovac's COVID-19 vaccine, a move likely to reduce public trust in the Chinese product that has been their main inoculation tool.    </p><p>   Some countries including Turkey and the United Arab Emirates</p><p>have already started giving a booster shot to those inoculated with Chinese vaccines amid concerns that they may not be as effective against new and more transmissible coronavirus variants.  </p><p>   But the challenges facing Southeast Asia are much bigger. Many countries in the region rely heavily on Chinese vaccines due to tight supplies of Western products, and have low vaccination rates of less than 10%.</p><p>   They are also battling a record-breaking surge in new cases and deaths, led by the highly contagious Delta variant, while rising infections among medical workers despite being fully immunised with the Sinovac    shots have stretched already thin healthcare systems.</p><p>   \"There's a lot of doctors and medical workers who have been vaccinated twice but endured medium and severe symptoms, or even died,\" Slamet Budiarto, deputy chief of the Indonesian Medical Association, told parliament on Monday.</p><p>   Indonesia has vaccinated millions of its healthcare workers with the Sinovac shot and thousands of them are now testing positive for COVID-19.   </p><p>   \"It is the time for medical workers to get a third booster to protect them from the impact of more vicious and worrying new variants,\" said Melki Laka Lena, deputy chairman of the parliamentary commission overseeing health. </p><p>   Siti Nadia Tarmizi, an official from Indonesia's health ministry, said it is waiting for recommendations from immunization advisory group and Indonesia's Food and Drug Agency (BPOM) about the use of a booster shot.</p><p>   While some real world data showed the Sinovac vaccine is effective against hospitalisation and severe COVID-19 cases, there is no detailed data yet on its effectiveness against the Delta variant, first identified in India. </p><p>   Thailand, which expects to receive a donation of 1.5 million Pfizer-BioNtech     shots from the United States later this month, plans to use it in inoculating its 700,000 medical workers, most of whom have already received two shots of Sinovac. </p><p>   Senior health official Udom Kachintorn said the plan was aimed at increasing immunity, as the Delta variant increases case loads and scores of medical workers who had been fully vaccinated with the Sinovac became infected.</p><p>   A leaked Thai health ministry document this week showed that the government was concerned about such a move sending a wrong signal to the public because it would be admitting that the Sinovac vaccine was not effective.  </p><p>   \"It will definitely have an impact on the trust in the vaccine,\" said Dicky Budiman, an epidemiologist at Australia's Griffith University.</p><p>   \"The vaccine isn't necessarily ineffective, but its efficacy slides down after six months. That's my prediction,\" he said, recommending authorities consider a booster shot as a solution and communicate the problems with the public.</p><p>   Thai authorities have defended the vaccine's use and its plan to purchase more Sinovac vaccines. </p><p>   \"Don't downgrade Sinovac even though we know efficacy is lower. It reduces the number of patients with critical condition, and fatalities,\" Udom said. </p><p>   Indonesian doctors also acknowledge that Sinovac might not be the best vaccine on the market, but say that for now that is all they have, and that is better than nothing. </p><p>   \"Up to now because we cannot produce (a vaccine) we have no (other) option,\" said Eka Julianta Wahjoepramono, the dean of the medical school at Pelita Harapan University.</p><p>   \"Sinovac is the only choice,\" said Eka, who was fully vaccinated with the Sinovac but got a severe case of COVID-19 last month.    </p><p>   Sinovac did not reply to a Reuters' request for comment.</p><p>   'TIMELY RAIN' OR STILL DOUBTFUL</p><p>   Doubts about the effectiveness of Chinese vaccines threaten to undermine China's so-called \"vaccine diplomacy,\" through which Beijing has sought to increase its diplomatic influence around the world. China has shipped hundreds of millions of doses of locally developed COVID-19 shots overseas.</p><p>   Singapore said this week people who received the Sinovac shots are excluded from its count of total vaccinations due to a lack of efficacy data for the vaccine, especially against the contagious Delta variant.  </p><p>   \"We don't really have a medical or scientific basis or have the data now to establish how effective Sinovac is in terms of infection and severe illnesses on Delta,\" health minister Ong Ye Kung said.</p><p>   China reiterated that its vaccines are safe and effective.</p><p>   \"Chinese vaccines have earned a good reputation in the international community with their safety and efficacy widely recognised,\" foreign ministry spokesman Wang Wenbin said on Monday in response to a question about whether other countries have expressed concerns about Chinese vaccines. </p><p>   \"To date over 100 countries have approved Chinese vaccines... The first batch of vaccines to arrive in many developing nations are from China. They refer to the Chinese doses as 'timely rain'.\"</p><p> (Reporting by Chayut Setboonsarng and Panarat Thepgumpanat in Bangkok; Additional reporting by Karen Lema in Manila, Jonathan Spicer in Istanbul, Stanley Widanto and Agustinus Beo Da Costa in Jakarta, and Kate Lamb in Sydney, Aradhana Aravindan in Singapore and Ryan Woo in Beijing; Editing by Miyoung Kim and Kim Coghill)</p><p>((chayut.setboonsarng@tr.com, <a href=\"https://laohu8.com/S/TWTR\">Twitter</a>: @ChayutSet; +66854849033;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SVA":"科兴生物","PFE":"辉瑞","MRNA":"Moderna, Inc."},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2149434973","content_text":"By Chayut Setboonsarng and Stanley Widianto   BANGKOK/JAKARTA, July 8 (Reuters) - Indonesia and Thailand are considering offering a booster shot to their medical workers immunized with Sinovac's COVID-19 vaccine, a move likely to reduce public trust in the Chinese product that has been their main inoculation tool.       Some countries including Turkey and the United Arab Emirateshave already started giving a booster shot to those inoculated with Chinese vaccines amid concerns that they may not be as effective against new and more transmissible coronavirus variants.     But the challenges facing Southeast Asia are much bigger. Many countries in the region rely heavily on Chinese vaccines due to tight supplies of Western products, and have low vaccination rates of less than 10%.   They are also battling a record-breaking surge in new cases and deaths, led by the highly contagious Delta variant, while rising infections among medical workers despite being fully immunised with the Sinovac    shots have stretched already thin healthcare systems.   \"There's a lot of doctors and medical workers who have been vaccinated twice but endured medium and severe symptoms, or even died,\" Slamet Budiarto, deputy chief of the Indonesian Medical Association, told parliament on Monday.   Indonesia has vaccinated millions of its healthcare workers with the Sinovac shot and thousands of them are now testing positive for COVID-19.      \"It is the time for medical workers to get a third booster to protect them from the impact of more vicious and worrying new variants,\" said Melki Laka Lena, deputy chairman of the parliamentary commission overseeing health.    Siti Nadia Tarmizi, an official from Indonesia's health ministry, said it is waiting for recommendations from immunization advisory group and Indonesia's Food and Drug Agency (BPOM) about the use of a booster shot.   While some real world data showed the Sinovac vaccine is effective against hospitalisation and severe COVID-19 cases, there is no detailed data yet on its effectiveness against the Delta variant, first identified in India.    Thailand, which expects to receive a donation of 1.5 million Pfizer-BioNtech     shots from the United States later this month, plans to use it in inoculating its 700,000 medical workers, most of whom have already received two shots of Sinovac.    Senior health official Udom Kachintorn said the plan was aimed at increasing immunity, as the Delta variant increases case loads and scores of medical workers who had been fully vaccinated with the Sinovac became infected.   A leaked Thai health ministry document this week showed that the government was concerned about such a move sending a wrong signal to the public because it would be admitting that the Sinovac vaccine was not effective.     \"It will definitely have an impact on the trust in the vaccine,\" said Dicky Budiman, an epidemiologist at Australia's Griffith University.   \"The vaccine isn't necessarily ineffective, but its efficacy slides down after six months. That's my prediction,\" he said, recommending authorities consider a booster shot as a solution and communicate the problems with the public.   Thai authorities have defended the vaccine's use and its plan to purchase more Sinovac vaccines.    \"Don't downgrade Sinovac even though we know efficacy is lower. It reduces the number of patients with critical condition, and fatalities,\" Udom said.    Indonesian doctors also acknowledge that Sinovac might not be the best vaccine on the market, but say that for now that is all they have, and that is better than nothing.    \"Up to now because we cannot produce (a vaccine) we have no (other) option,\" said Eka Julianta Wahjoepramono, the dean of the medical school at Pelita Harapan University.   \"Sinovac is the only choice,\" said Eka, who was fully vaccinated with the Sinovac but got a severe case of COVID-19 last month.       Sinovac did not reply to a Reuters' request for comment.   'TIMELY RAIN' OR STILL DOUBTFUL   Doubts about the effectiveness of Chinese vaccines threaten to undermine China's so-called \"vaccine diplomacy,\" through which Beijing has sought to increase its diplomatic influence around the world. China has shipped hundreds of millions of doses of locally developed COVID-19 shots overseas.   Singapore said this week people who received the Sinovac shots are excluded from its count of total vaccinations due to a lack of efficacy data for the vaccine, especially against the contagious Delta variant.     \"We don't really have a medical or scientific basis or have the data now to establish how effective Sinovac is in terms of infection and severe illnesses on Delta,\" health minister Ong Ye Kung said.   China reiterated that its vaccines are safe and effective.   \"Chinese vaccines have earned a good reputation in the international community with their safety and efficacy widely recognised,\" foreign ministry spokesman Wang Wenbin said on Monday in response to a question about whether other countries have expressed concerns about Chinese vaccines.    \"To date over 100 countries have approved Chinese vaccines... The first batch of vaccines to arrive in many developing nations are from China. They refer to the Chinese doses as 'timely rain'.\" (Reporting by Chayut Setboonsarng and Panarat Thepgumpanat in Bangkok; Additional reporting by Karen Lema in Manila, Jonathan Spicer in Istanbul, Stanley Widanto and Agustinus Beo Da Costa in Jakarta, and Kate Lamb in Sydney, Aradhana Aravindan in Singapore and Ryan Woo in Beijing; Editing by Miyoung Kim and Kim Coghill)((chayut.setboonsarng@tr.com, Twitter: @ChayutSet; +66854849033;))","news_type":1},"isVote":1,"tweetType":1,"viewCount":550,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140540351,"gmtCreate":1625667031373,"gmtModify":1703746035667,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Didi downdown","listText":"Didi downdown","text":"Didi downdown","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140540351","repostId":"2149390009","repostType":2,"isVote":1,"tweetType":1,"viewCount":552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140554373,"gmtCreate":1625666995892,"gmtModify":1703746032724,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Any hope to go further?&nbsp;","listText":"Any hope to go further?&nbsp;","text":"Any hope to go further?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140554373","repostId":"156697232","repostType":1,"repost":{"id":156697232,"gmtCreate":1625216167326,"gmtModify":1703738540313,"author":{"id":"3575931476822699","authorId":"3575931476822699","name":"Zified","avatar":"https://static.tigerbbs.com/2504476ab9db7b38867d7694e9c634e7","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3575931476822699","authorIdStr":"3575931476822699"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/SPOT\">$Spotify Technology S.A.(SPOT)$</a>Hmm","listText":"<a href=\"https://laohu8.com/S/SPOT\">$Spotify Technology S.A.(SPOT)$</a>Hmm","text":"$Spotify Technology S.A.(SPOT)$Hmm","images":[{"img":"https://static.tigerbbs.com/6f5e7562c24cbb8cd16f17a4ea27cec5","width":"750","height":"1224"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/156697232","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":133,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157682904,"gmtCreate":1625580434208,"gmtModify":1703744286988,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157682904","repostId":"1118465420","repostType":4,"repost":{"id":"1118465420","pubTimestamp":1625580135,"share":"https://ttm.financial/m/news/1118465420?lang=&edition=fundamental","pubTime":"2021-07-06 22:02","market":"us","language":"en","title":"Advaxis Jumps on Deal to Be Bought by Biosight","url":"https://stock-news.laohu8.com/highlight/detail?id=1118465420","media":"Thestreet","summary":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Bi","content":"<p>Advaxis&nbsp;(<b>ADXS</b>)&nbsp;shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.</p>\n<p>At closing, Biosight holders will own 75%&nbsp;of the company and&nbsp;Advaxis holders will own 25%.</p>\n<p>Advaxis,&nbsp;Princeton, N.J.,&nbsp;recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.</p>\n<p>The combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.</p>\n<p>“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.</p>\n<p>The new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.</p>\n<p>In other healthcare news, Iterum Therapeutics&nbsp;(<b>ITRM</b>) -Get Report&nbsp;said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections&nbsp;were found.</p>\n<p>The Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.</p>\n<p>Also last week,Anavex Life Sciences&nbsp;(<b>AVXL</b>) -Get Report&nbsp;reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.</p>\n<p>JonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Advaxis Jumps on Deal to Be Bought by Biosight</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdvaxis Jumps on Deal to Be Bought by Biosight\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-06 22:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and ...</p>\n\n<a href=\"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADXS":"Ayala Pharmaceuticals, Inc."},"source_url":"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118465420","content_text":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and Advaxis holders will own 25%.\nAdvaxis, Princeton, N.J., recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.\nThe combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.\n“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.\nThe new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.\nIn other healthcare news, Iterum Therapeutics (ITRM) -Get Report said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections were found.\nThe Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.\nAlso last week,Anavex Life Sciences (AVXL) -Get Report reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.\nJonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":155693485,"gmtCreate":1625408359247,"gmtModify":1703741402582,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Reject!!","listText":"Reject!!","text":"Reject!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/155693485","repostId":"2148807264","repostType":4,"repost":{"id":"2148807264","pubTimestamp":1625368443,"share":"https://ttm.financial/m/news/2148807264?lang=&edition=fundamental","pubTime":"2021-07-04 11:14","market":"us","language":"en","title":"Dutch Court Rejects Facebook's Offer To Dismiss Privacy Lawsuit In Netherlands","url":"https://stock-news.laohu8.com/highlight/detail?id=2148807264","media":"Benzinga","summary":"On Saturday, an Amsterdam court ruled that the privacy litigation against Facebook Inc. (NASDAQ: FB)","content":"<p><img src=\"https://static.tigerbbs.com/a9c697ef0765f58a6901d25f60c1bf6e\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<p>On Saturday, an&nbsp;Amsterdam court&nbsp;ruled that the privacy litigation against&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc.</b>&nbsp;(NASDAQ: FB) in the Netherlands can proceed. The case will be heard in October, the&nbsp;Verge&nbsp;reported.</p>\n<p>The court rejected Facebook’s offer to have the lawsuit from two non-profit groups thrown out.</p>\n<p>The Amsterdam-based Data Privacy Foundation and Dutch consumer advocacy organization Consumentenbond have filed a lawsuit against Facebook for violating the European Union privacy law.</p>\n<p>According to the lawsuit, Facebook has not provided details about the information it gathers from users. Facebook has also not mentioned what it does with the data; hence, it cannot process it.</p>\n<p>Facebook denies the allegations and claims it respects user privacy and provides people with meaningful control over how their data gets exploited.</p>\n<p>According to the court, “The Data Privacy Foundation may litigate before the Dutch court on behalf of Dutch users of the Facebook service against Facebook about whether Facebook has violated the privacy of its users.”</p>\n<p>European Union law allows for collective redress across several areas, including data protection rights, enabling qualified entities to bring representative actions on behalf of rights holders.</p>\n<p>Facebook claims that the Amsterdam court doesn’t have jurisdiction over its European business, which it argues is subject to Irish law.</p>\n<p><b>Price Action:</b>&nbsp;FB shares closed higher by 0.09% at $354.70 on Friday.</p>\n<p></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dutch Court Rejects Facebook's Offer To Dismiss Privacy Lawsuit In Netherlands</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDutch Court Rejects Facebook's Offer To Dismiss Privacy Lawsuit In Netherlands\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-04 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/dutch-court-rejects-facebooks-offer-202803054.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On Saturday, an Amsterdam court ruled that the privacy litigation against Facebook Inc. (NASDAQ: FB) in the Netherlands can proceed. The case will be heard in October, the Verge reported.\nThe court ...</p>\n\n<a href=\"https://finance.yahoo.com/news/dutch-court-rejects-facebooks-offer-202803054.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","09086":"华夏纳指-U"},"source_url":"https://finance.yahoo.com/news/dutch-court-rejects-facebooks-offer-202803054.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2148807264","content_text":"On Saturday, an Amsterdam court ruled that the privacy litigation against Facebook Inc. (NASDAQ: FB) in the Netherlands can proceed. The case will be heard in October, the Verge reported.\nThe court rejected Facebook’s offer to have the lawsuit from two non-profit groups thrown out.\nThe Amsterdam-based Data Privacy Foundation and Dutch consumer advocacy organization Consumentenbond have filed a lawsuit against Facebook for violating the European Union privacy law.\nAccording to the lawsuit, Facebook has not provided details about the information it gathers from users. Facebook has also not mentioned what it does with the data; hence, it cannot process it.\nFacebook denies the allegations and claims it respects user privacy and provides people with meaningful control over how their data gets exploited.\nAccording to the court, “The Data Privacy Foundation may litigate before the Dutch court on behalf of Dutch users of the Facebook service against Facebook about whether Facebook has violated the privacy of its users.”\nEuropean Union law allows for collective redress across several areas, including data protection rights, enabling qualified entities to bring representative actions on behalf of rights holders.\nFacebook claims that the Amsterdam court doesn’t have jurisdiction over its European business, which it argues is subject to Irish law.\nPrice Action: FB shares closed higher by 0.09% at $354.70 on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156665904,"gmtCreate":1625219100108,"gmtModify":1703738601929,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Mehhhh","listText":"Mehhhh","text":"Mehhhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/156665904","repostId":"1107527256","repostType":4,"repost":{"id":"1107527256","pubTimestamp":1625218747,"share":"https://ttm.financial/m/news/1107527256?lang=&edition=fundamental","pubTime":"2021-07-02 17:39","market":"us","language":"en","title":"Why Zoom Video Stock Jumped 17% in June","url":"https://stock-news.laohu8.com/highlight/detail?id=1107527256","media":"Motley Fool","summary":"Shares of the videoconferencing platform gained last month on a solid earnings report and other tail","content":"<p>Shares of the videoconferencing platform gained last month on a solid earnings report and other tailwinds.</p>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b>Zoom Video Communications</b>(NASDAQ:ZM)jumped 17% last month, according to data from&nbsp;S&amp;P Global Market Intelligence.</p>\n<p>The videoconferencing leader benefited from a strong first-quarter earnings report, some bullish analyst notes, an acquisition, and concerns about the spreading COVID-19 Delta variant.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/5c45583694304bcdd2e20c758dcee810\" tg-width=\"2000\" tg-height=\"1355\"><span>IMAGE SOURCE: ZOOM.</span></p>\n<p>As you can see from the chart below, the&nbsp;cloud stock&nbsp;gained steadily over the course of the month, riding a broader trend in growth and tech stocks.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/49688704c96624e4f0979ac01ea9016f\" tg-width=\"720\" tg-height=\"387\"><span>ZM DATA BY YCHARTS.</span></p>\n<p><b>So what</b></p>\n<p>Zoom kicked off the month with another round of smashing growth as revenue rose 191% to $956.2 million in its first-quarter earnings report, easily beating estimates at $906.3 million. Customers with more than 10 employees nearly doubled to 497,000.</p>\n<p>Its bottom-line performance was also impressive as adjusted operating income jumped more than seven times from the year-ago quarter to $400.9 million, equal to a 41.9% adjusted operating profit margin. Adjusted earnings per share reached $1.32, topping the consensus at $0.99.</p>\n<p>Despite the strong results, investors shrugged off the results as the stock was mostly unchanged on the news. However, it jumped at the end of the month's first week on news that Cathie Wood's ARK Invest bought 96,100 shares.</p>\n<p>The following week, the&nbsp;stock gained&nbsp;on a pair of bullish analyst notes as it was upgraded to buy at Argus, and RBC Capital analyst Rishi Jaluria rated Zoom outperform and called it a top pick.</p>\n<p>Lastly, Zoom jumped at the end of the month after saying it would acquire Kites, a real-time machine translation start-up to help Zoom with its machine translation, a valuable add-on service for videoconferencing.</p>\n<p><b>Now what</b></p>\n<p>Zoom will face difficult comparisons over the rest of the year as the company laps its blowout performance during the pandemic. But it hiked its guidance for the full year in the first-quarter report, calling for revenue of $3.975 billion to $3.99 billion, above its prior range of $3.76 billion to $3.78 billion. It also expects adjusted earnings per share of $4.56 to $4.61, up from an earlier forecast of $3.59 to $3.65.</p>\n<p>With that forecast, Zoom doesn't even look that expensive at a price-to-earnings ratio of less than 90, especially compared to some of its software-as-a-service peers that aren't even profitable. Though last year's growth was certainly an anomaly, the future still looks bright for Zoom.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Zoom Video Stock Jumped 17% in June</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Zoom Video Stock Jumped 17% in June\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-02 17:39 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/01/why-zoom-video-stock-jumped-17/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of the videoconferencing platform gained last month on a solid earnings report and other tailwinds.\nWhat happened\nShares of Zoom Video Communications(NASDAQ:ZM)jumped 17% last month, according ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/01/why-zoom-video-stock-jumped-17/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom"},"source_url":"https://www.fool.com/investing/2021/07/01/why-zoom-video-stock-jumped-17/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1107527256","content_text":"Shares of the videoconferencing platform gained last month on a solid earnings report and other tailwinds.\nWhat happened\nShares of Zoom Video Communications(NASDAQ:ZM)jumped 17% last month, according to data from S&P Global Market Intelligence.\nThe videoconferencing leader benefited from a strong first-quarter earnings report, some bullish analyst notes, an acquisition, and concerns about the spreading COVID-19 Delta variant.\nIMAGE SOURCE: ZOOM.\nAs you can see from the chart below, the cloud stock gained steadily over the course of the month, riding a broader trend in growth and tech stocks.\nZM DATA BY YCHARTS.\nSo what\nZoom kicked off the month with another round of smashing growth as revenue rose 191% to $956.2 million in its first-quarter earnings report, easily beating estimates at $906.3 million. Customers with more than 10 employees nearly doubled to 497,000.\nIts bottom-line performance was also impressive as adjusted operating income jumped more than seven times from the year-ago quarter to $400.9 million, equal to a 41.9% adjusted operating profit margin. Adjusted earnings per share reached $1.32, topping the consensus at $0.99.\nDespite the strong results, investors shrugged off the results as the stock was mostly unchanged on the news. However, it jumped at the end of the month's first week on news that Cathie Wood's ARK Invest bought 96,100 shares.\nThe following week, the stock gained on a pair of bullish analyst notes as it was upgraded to buy at Argus, and RBC Capital analyst Rishi Jaluria rated Zoom outperform and called it a top pick.\nLastly, Zoom jumped at the end of the month after saying it would acquire Kites, a real-time machine translation start-up to help Zoom with its machine translation, a valuable add-on service for videoconferencing.\nNow what\nZoom will face difficult comparisons over the rest of the year as the company laps its blowout performance during the pandemic. But it hiked its guidance for the full year in the first-quarter report, calling for revenue of $3.975 billion to $3.99 billion, above its prior range of $3.76 billion to $3.78 billion. It also expects adjusted earnings per share of $4.56 to $4.61, up from an earlier forecast of $3.59 to $3.65.\nWith that forecast, Zoom doesn't even look that expensive at a price-to-earnings ratio of less than 90, especially compared to some of its software-as-a-service peers that aren't even profitable. Though last year's growth was certainly an anomaly, the future still looks bright for Zoom.","news_type":1},"isVote":1,"tweetType":1,"viewCount":118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158835466,"gmtCreate":1625142855255,"gmtModify":1703736993379,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"YES","listText":"YES","text":"YES","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/158835466","repostId":"2148840842","repostType":4,"repost":{"id":"2148840842","pubTimestamp":1625139355,"share":"https://ttm.financial/m/news/2148840842?lang=&edition=fundamental","pubTime":"2021-07-01 19:35","market":"us","language":"en","title":"3 Top Stocks That'll Make You Richer in July (and Beyond)","url":"https://stock-news.laohu8.com/highlight/detail?id=2148840842","media":"Motley Fool","summary":"These companies are innovators within their respective high-growth industries.","content":"<p>Congratulations, folks, we've made it to the halfway point of 2021, and things are beginning to look up. <a href=\"https://laohu8.com/S/TWOA.U\">Two</a> of the three major U.S. stock indexes hit an all-time high last week, and U.S. vaccination rates continue to head higher, signaling that an end to the pandemic, at least within the borders of the U.S., may be in sight.</p>\n<p>Yet, even with equities pricier than they've seemingly been in close to two decades, value abounds for long-term investors. As we head into July, the following three top stocks stand out as particularly attractive, and they have a genuine shot at making investors richer this month, and well beyond.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/caeb5728f1df2932f1493ee7cf2c6b47\" tg-width=\"700\" tg-height=\"467\"><span>Image source: Getty Images.</span></p>\n<h2>Teladoc Health</h2>\n<p>To begin with, leading telehealth services provider <b>Teladoc Health</b> (NYSE:TDOC) looks like a bargain for growth seekers after losing nearly half of its value since mid-February.</p>\n<p>If there's a knock against Teladoc Health, it's that there are questions about the company's growth sustainability once we move beyond the pandemic. This is to say that Teladoc was served up on a silver platter in 2020. With physicians purposefully keeping high-risk patients out of their offices last year, many turned to virtual visits as a solution. As a result, the company handled 10.59 million total visits, up from 4.14 million in 2019.</p>\n<p>While these growth concerns could prove palpable in the extremely short-term when life does return to some semblance of normal, the proof is in the pudding that telehealth services are a game-changer and here to stay. Being able to consult with a physician from home is substantially more convenient for patients. On the flipside, physicians should have easier access to vital health metrics for chronically ill patients with telemedicine services. The expectation is this'll lead to improved patient outcomes, which means less money coming out of the pockets of health insurers.</p>\n<p>The icing on the cake is that Teladoc grew its annual sales by an average of 74% in the six years leading up to the coronavirus pandemic. Again, despite post-pandemic growth concerns, both the logic of telehealth and the sales data demonstrate that it's a driving force of change within the healthcare industry.</p>\n<p>What's more, Teladoc added an important puzzle piece in the fourth quarter of 2020 with the acquisition of applied health signals company Livongo Health. Livongo collects large amounts of data on patients with chronic illnesses, and with the help of artificial intelligence sends tips to its members to help them lead healthier lives. It had 658,000 diabetes members at the end of March, but is expanding its reach to include folks with hypertension and weight management issues. This means Livongo's services will cover a large swath of the U.S. adult population.</p>\n<p>Teladoc and Livongo are just scratching the surface of their potential as a broad-based personalized healthcare service. This could well be <a href=\"https://laohu8.com/S/AONE\">one</a> of a handful of transformative healthcare companies of the decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/af564c8e93ad6657d5fad263a6d0b483\" tg-width=\"700\" tg-height=\"525\"><span>Image source: Getty Images.</span></p>\n<h2>Columbia Care</h2>\n<p>Another smart place to consider putting your money to work right now is in the cannabis industry. Understand, though, that the pot industry is bifurcated, with Canada largely underperforming and U.S. marijuana stocks outperforming. Since the U.S. is the largest cannabis market in the world by a longshot, <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the top stocks to consider buying right now is under-the-radar U.S. multistate operator (MSO) <b>Columbia Care</b> (OTC:CCHWF).</p>\n<p>Although a lot of folks are waiting for the Biden administration to tackle cannabis reform, it's simply not needed. While it'd be great if restrictions were lifted for U.S. pot stocks, the fact is that 36 states have legalized weed in some capacity, 11 of which are also currently selling adult-use cannabis in dispensaries. As long as the federal Justice Department allows states to regulate their own industries, this will be a high-growth opportunity for investors.</p>\n<p>The interesting thing about the lesser-known Columbia Care is that it was all-in on medical marijuana until recently. When U.S. states began waving the green flag on recreational marijuana, it began pivoting its approach to include this larger pool of potential consumers. According to the company, it controls 92 dispensaries and 30 manufacturing/processing facilities, if you take into account all pending acquisitions.</p>\n<p>All MSOs offer their own unique blueprint for growth in the United States. For Columbia Care, acquisitions and carefully plotted expansion have been its ticket to higher sales. It recently closed on its purchase of Green Leaf Medical, purchased The Green Solution last year, and announced the acquisition of The Medicine Man in the Denver, Colorado metro area last month. Although integrating these acquisitions and using its common stock as capital could hinder its bottom-line operating results in 2021, things should vastly improve in 2022 and beyond.</p>\n<p>Columbia Care is also building a presence in a number of key limited-license states, such as Pennsylvania, Maryland, Ohio, and Virginia. Limited-license states either cap the number of retail, cultivation, or processing licenses they issue, or issue licenses based on jurisdiction. The point being that Columbia Care is seeking out high-dollar states where competition is being dialed back purposefully by regulators.</p>\n<p>Between rapid organic growth in legalized states and its aggressive but purpose-driven acquisition strategy, Columbia Care is expected to top $500 million in sales this year and $1 billion by 2023. This means investors can scoop up shares of Columbia Care today for less than two times Wall Street's full-year sales forecast for 2023. That's inexpensive for such a robust growth stock.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/a023694ce4b4e40463c6f0f2f29037f0\" tg-width=\"700\" tg-height=\"466\"><span>Image source: Getty Images.</span></p>\n<h2>PubMatic</h2>\n<p>The third top stock that'll make investors a lot richer in July (and beyond) is cloud-based advertising technology company <b>PubMatic</b> (NASDAQ:PUBM).</p>\n<p>In ye olden days (prior to the internet), connecting advertisers with publishers and agreeing on a price was a time-consuming, human-driven process. But since the advent of the internet, developers and publishers have been refining how ads reach users, as well as how these advertisements should be priced. This has given rise to programmatic advertising, which is PubMatic's stomping ground.</p>\n<p>In simple terms, programmatic advertising involves the real-time buying, selling, and optimization of ads by machine-learning algorithms. Connecting advertisers with publishers occurs two ways: via demand-side platforms (DSP) or sell/supply-side platforms (SSP). DSPs allow the advertisers to control their advertising campaigns. Meanwhile, SSPs empower publishers to sell their display space to advertisers.</p>\n<p>PubMatic's dynamic cloud-based infrastructure operates as an SSP, which comes with a number of key advantages. SSPs limit the number of similar ad impressions to a single viewer, allow publishers to set a price floor for advertising space, and use machine learning to select the best ad for a user, not the one that necessarily boasts the highest price. This optimized focus for publishers resulted in PubMatic recognizing a net dollar-based retention of 130% for the March-ended quarter. In other words, existing publishers on its platform spent 30% more in Q1 2021 than they did in the year-ago quarter.</p>\n<p>What we're witnessing in the advertising space is a clear push toward digital. According to a May investor presentation from the company, global digital ad spend should grow by an annualized rate of 10% through 2024, with even faster annual growth expected for mobile, digital video, and connected TV (CTV)/over-the-top (OTT) programmatic ad spend. This focus on mobile and CTV/OTT is precisely why PubMatic is outpacing the industry in terms of top-line growth, and explains why it raised its full-year 2021 sales guidance.</p>\n<p>If PubMatic can continue to grow sales by 15% to 20% annually, it could very easily make patient investors a lot richer.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Stocks That'll Make You Richer in July (and Beyond)</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Stocks That'll Make You Richer in July (and Beyond)\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-01 19:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/07/01/3-top-stocks-thatll-make-you-richer-in-july/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Congratulations, folks, we've made it to the halfway point of 2021, and things are beginning to look up. Two of the three major U.S. stock indexes hit an all-time high last week, and U.S. vaccination ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/07/01/3-top-stocks-thatll-make-you-richer-in-july/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TDOC":"Teladoc Health Inc.","PUBM":"PubMatic, Inc."},"source_url":"https://www.fool.com/investing/2021/07/01/3-top-stocks-thatll-make-you-richer-in-july/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2148840842","content_text":"Congratulations, folks, we've made it to the halfway point of 2021, and things are beginning to look up. Two of the three major U.S. stock indexes hit an all-time high last week, and U.S. vaccination rates continue to head higher, signaling that an end to the pandemic, at least within the borders of the U.S., may be in sight.\nYet, even with equities pricier than they've seemingly been in close to two decades, value abounds for long-term investors. As we head into July, the following three top stocks stand out as particularly attractive, and they have a genuine shot at making investors richer this month, and well beyond.\nImage source: Getty Images.\nTeladoc Health\nTo begin with, leading telehealth services provider Teladoc Health (NYSE:TDOC) looks like a bargain for growth seekers after losing nearly half of its value since mid-February.\nIf there's a knock against Teladoc Health, it's that there are questions about the company's growth sustainability once we move beyond the pandemic. This is to say that Teladoc was served up on a silver platter in 2020. With physicians purposefully keeping high-risk patients out of their offices last year, many turned to virtual visits as a solution. As a result, the company handled 10.59 million total visits, up from 4.14 million in 2019.\nWhile these growth concerns could prove palpable in the extremely short-term when life does return to some semblance of normal, the proof is in the pudding that telehealth services are a game-changer and here to stay. Being able to consult with a physician from home is substantially more convenient for patients. On the flipside, physicians should have easier access to vital health metrics for chronically ill patients with telemedicine services. The expectation is this'll lead to improved patient outcomes, which means less money coming out of the pockets of health insurers.\nThe icing on the cake is that Teladoc grew its annual sales by an average of 74% in the six years leading up to the coronavirus pandemic. Again, despite post-pandemic growth concerns, both the logic of telehealth and the sales data demonstrate that it's a driving force of change within the healthcare industry.\nWhat's more, Teladoc added an important puzzle piece in the fourth quarter of 2020 with the acquisition of applied health signals company Livongo Health. Livongo collects large amounts of data on patients with chronic illnesses, and with the help of artificial intelligence sends tips to its members to help them lead healthier lives. It had 658,000 diabetes members at the end of March, but is expanding its reach to include folks with hypertension and weight management issues. This means Livongo's services will cover a large swath of the U.S. adult population.\nTeladoc and Livongo are just scratching the surface of their potential as a broad-based personalized healthcare service. This could well be one of a handful of transformative healthcare companies of the decade.\nImage source: Getty Images.\nColumbia Care\nAnother smart place to consider putting your money to work right now is in the cannabis industry. Understand, though, that the pot industry is bifurcated, with Canada largely underperforming and U.S. marijuana stocks outperforming. Since the U.S. is the largest cannabis market in the world by a longshot, one of the top stocks to consider buying right now is under-the-radar U.S. multistate operator (MSO) Columbia Care (OTC:CCHWF).\nAlthough a lot of folks are waiting for the Biden administration to tackle cannabis reform, it's simply not needed. While it'd be great if restrictions were lifted for U.S. pot stocks, the fact is that 36 states have legalized weed in some capacity, 11 of which are also currently selling adult-use cannabis in dispensaries. As long as the federal Justice Department allows states to regulate their own industries, this will be a high-growth opportunity for investors.\nThe interesting thing about the lesser-known Columbia Care is that it was all-in on medical marijuana until recently. When U.S. states began waving the green flag on recreational marijuana, it began pivoting its approach to include this larger pool of potential consumers. According to the company, it controls 92 dispensaries and 30 manufacturing/processing facilities, if you take into account all pending acquisitions.\nAll MSOs offer their own unique blueprint for growth in the United States. For Columbia Care, acquisitions and carefully plotted expansion have been its ticket to higher sales. It recently closed on its purchase of Green Leaf Medical, purchased The Green Solution last year, and announced the acquisition of The Medicine Man in the Denver, Colorado metro area last month. Although integrating these acquisitions and using its common stock as capital could hinder its bottom-line operating results in 2021, things should vastly improve in 2022 and beyond.\nColumbia Care is also building a presence in a number of key limited-license states, such as Pennsylvania, Maryland, Ohio, and Virginia. Limited-license states either cap the number of retail, cultivation, or processing licenses they issue, or issue licenses based on jurisdiction. The point being that Columbia Care is seeking out high-dollar states where competition is being dialed back purposefully by regulators.\nBetween rapid organic growth in legalized states and its aggressive but purpose-driven acquisition strategy, Columbia Care is expected to top $500 million in sales this year and $1 billion by 2023. This means investors can scoop up shares of Columbia Care today for less than two times Wall Street's full-year sales forecast for 2023. That's inexpensive for such a robust growth stock.\nImage source: Getty Images.\nPubMatic\nThe third top stock that'll make investors a lot richer in July (and beyond) is cloud-based advertising technology company PubMatic (NASDAQ:PUBM).\nIn ye olden days (prior to the internet), connecting advertisers with publishers and agreeing on a price was a time-consuming, human-driven process. But since the advent of the internet, developers and publishers have been refining how ads reach users, as well as how these advertisements should be priced. This has given rise to programmatic advertising, which is PubMatic's stomping ground.\nIn simple terms, programmatic advertising involves the real-time buying, selling, and optimization of ads by machine-learning algorithms. Connecting advertisers with publishers occurs two ways: via demand-side platforms (DSP) or sell/supply-side platforms (SSP). DSPs allow the advertisers to control their advertising campaigns. Meanwhile, SSPs empower publishers to sell their display space to advertisers.\nPubMatic's dynamic cloud-based infrastructure operates as an SSP, which comes with a number of key advantages. SSPs limit the number of similar ad impressions to a single viewer, allow publishers to set a price floor for advertising space, and use machine learning to select the best ad for a user, not the one that necessarily boasts the highest price. This optimized focus for publishers resulted in PubMatic recognizing a net dollar-based retention of 130% for the March-ended quarter. In other words, existing publishers on its platform spent 30% more in Q1 2021 than they did in the year-ago quarter.\nWhat we're witnessing in the advertising space is a clear push toward digital. According to a May investor presentation from the company, global digital ad spend should grow by an annualized rate of 10% through 2024, with even faster annual growth expected for mobile, digital video, and connected TV (CTV)/over-the-top (OTT) programmatic ad spend. This focus on mobile and CTV/OTT is precisely why PubMatic is outpacing the industry in terms of top-line growth, and explains why it raised its full-year 2021 sales guidance.\nIf PubMatic can continue to grow sales by 15% to 20% annually, it could very easily make patient investors a lot richer.","news_type":1},"isVote":1,"tweetType":1,"viewCount":202,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158832756,"gmtCreate":1625142824175,"gmtModify":1703736988349,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"So slow&nbsp;","listText":"So slow&nbsp;","text":"So slow","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/158832756","repostId":"158108026","repostType":1,"repost":{"id":158108026,"gmtCreate":1625133558865,"gmtModify":1703736814006,"author":{"id":"3576748446044149","authorId":"3576748446044149","name":"JinXiong","avatar":"https://static.tigerbbs.com/6bffedf096818635d598ad25355be1e4","crmLevel":2,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3576748446044149","authorIdStr":"3576748446044149"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>trading sideways…","listText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>trading sideways…","text":"$ARK Innovation ETF(ARKK)$trading sideways…","images":[{"img":"https://static.tigerbbs.com/82265f9e3727c0daf89b2f25720cf493","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/158108026","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":108,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":158832024,"gmtCreate":1625142800868,"gmtModify":1703736987508,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>time to ??????","listText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>time to ??????","text":"$ARK Innovation ETF(ARKK)$time to ??????","images":[{"img":"https://static.tigerbbs.com/a4e05890d86e824c05ad36899181f118","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/158832024","isVote":1,"tweetType":1,"viewCount":101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159279501,"gmtCreate":1624972634803,"gmtModify":1703849116911,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>Not so magical after all :(","listText":"<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>Not so magical after all :(","text":"$Walt Disney(DIS)$Not so magical after all :(","images":[{"img":"https://static.tigerbbs.com/c2908737f01d2968c4d89244e68b3844","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159279501","isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":159270401,"gmtCreate":1624972583403,"gmtModify":1703849115605,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Gg","listText":"Gg","text":"Gg","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159270401","repostId":"1144845089","repostType":4,"repost":{"id":"1144845089","pubTimestamp":1624972212,"share":"https://ttm.financial/m/news/1144845089?lang=&edition=fundamental","pubTime":"2021-06-29 21:10","market":"us","language":"en","title":"Moderna’s Covid Shot Gets Regulatory Nod in India for Imports","url":"https://stock-news.laohu8.com/highlight/detail?id=1144845089","media":"Bloomberg","summary":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its pop","content":"<ul>\n <li>Indemnity details still being discussed, official says</li>\n <li>India has fully vaccinated only 4% of its population</li>\n</ul>\n<p>India’s drug regulator has cleared the imports of&nbsp;Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.</p>\n<p>The Drugs Controller General of India cleared pharmaceutical company&nbsp;Cipla Ltd.&nbsp;to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.</p>\n<p>“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”</p>\n<p>Paul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of&nbsp;indemnity&nbsp;to protect against legal liability in case of adverse effects.</p>\n<p>India had in April&nbsp;fast-tracked&nbsp;approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.</p>\n<p>India has been in talks with both&nbsp;Pfizer Inc.&nbsp;and Moderna to import additional inoculations needed for its immunization program.</p>\n<p>Despite halting all exports in April and benefiting from a huge vaccine industry, India has&nbsp;fully vaccinated&nbsp;just over 4% of its vast population.</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna’s Covid Shot Gets Regulatory Nod in India for Imports</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna’s Covid Shot Gets Regulatory Nod in India for Imports\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-29 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other ...</p>\n\n<a href=\"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.bloomberg.com/news/articles/2021-06-29/moderna-s-covid-shot-gets-regulatory-nod-in-india-for-imports?srnd=markets-vp","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144845089","content_text":"Indemnity details still being discussed, official says\nIndia has fully vaccinated only 4% of its population\n\nIndia’s drug regulator has cleared the imports of Moderna Inc.’s Covid-19 shot but other crucial details, including the granting of indemnity, were yet to be worked out, the head of the country’s vaccine panel said.\nThe Drugs Controller General of India cleared pharmaceutical company Cipla Ltd. to import the shots for restricted emergency use, V.K. Paul, who heads a panel advising Prime Minister Narendra Modi on inoculation efforts, said at a press briefing Tuesday.\n“A regulatory step has been taken that opens the pathways for imports,” Paul said. “Let wait how this opportunity will be used.”\nPaul said the Indian government was in talks with the vaccine manufacturer to iron out other issues, including the granting of indemnity to protect against legal liability in case of adverse effects.\nIndia had in April fast-tracked approvals for vaccines approved by overseas to have a wider pool of shots as it struggled to control a soaring second wave of infections that crippled its health-care system and overwhelmed burial grounds and crematoriums.\nIndia has been in talks with both Pfizer Inc. and Moderna to import additional inoculations needed for its immunization program.\nDespite halting all exports in April and benefiting from a huge vaccine industry, India has fully vaccinated just over 4% of its vast population.","news_type":1},"isVote":1,"tweetType":1,"viewCount":101,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":127019838,"gmtCreate":1624802203424,"gmtModify":1703845338050,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>After all that… ?","listText":"<a href=\"https://laohu8.com/S/ARKK\">$ARK Innovation ETF(ARKK)$</a>After all that… ?","text":"$ARK Innovation ETF(ARKK)$After all that… ?","images":[{"img":"https://static.tigerbbs.com/f0540176b70e3089f633c9c82ed40ee6","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/127019838","isVote":1,"tweetType":1,"viewCount":70,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0}],"hots":[{"id":170211047,"gmtCreate":1626434977389,"gmtModify":1703760095587,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Like please!!","listText":"Like please!!","text":"Like please!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":11,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/170211047","repostId":"2151509460","repostType":4,"isVote":1,"tweetType":1,"viewCount":553,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":146570310,"gmtCreate":1626093876430,"gmtModify":1703753189337,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Comment","listText":"Comment","text":"Comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://ttm.financial/post/146570310","repostId":"2150535792","repostType":4,"isVote":1,"tweetType":1,"viewCount":647,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":807127283,"gmtCreate":1628009045142,"gmtModify":1703499624000,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Big Apple&nbsp;","listText":"Big Apple&nbsp;","text":"Big Apple","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/807127283","repostId":"1171505764","repostType":4,"repost":{"id":"1171505764","pubTimestamp":1628004619,"share":"https://ttm.financial/m/news/1171505764?lang=&edition=fundamental","pubTime":"2021-08-03 23:30","market":"us","language":"en","title":"Apple’s Advertising Business Is Bigger Than You Think. It Could Get Bigger Still.","url":"https://stock-news.laohu8.com/highlight/detail?id=1171505764","media":"MarketWatch","summary":"Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted advertising.The decision has created the impression that Apple  is simply opposed to digital advertising. But that’s not actually the case. In fact, advertising is gradually becoming a material contributor to the company’s revenue base.In a research note Tuesday, Bernstein analystToni Sacconaghidoes a d","content":"<p>Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted advertising.</p>\n<p>The decision has created the impression that Apple (ticker: AAPL) is simply opposed to digital advertising. But that’s not actually the case. In fact, advertising is gradually becoming a material contributor to the company’s revenue base.</p>\n<p>In a research note Tuesday, Bernstein analystToni Sacconaghidoes a deep dive into Apple’s ad business. While the company doesn’t talk about the business much andprovides little disclosure, Sacconaghi estimates that Apple will generate about $3 billion in ad revenue in the September 2021 fiscal year, up from about $300 million in fiscal 2017. He thinks the total could grow to the $7 billion-to-$10 billion-a-year range by fiscal 2023 or 2024, boosting growth in Apple’s services business as much as three percentage points.</p>\n<p>Sacconaghi notes that most of Apple’s ad business is centered on search ads in the App Store. He says growth drivers in the business include the June addition of search ads in China, higher ad loads, and the introduction of banner ads to the store in May. He also points out that Apple generates modest revenue today—likely under $500 million a year—from ads in the Apple News and Stocks apps.</p>\n<p>There are other opportunities—including Apple Maps and Apple TV. Sacconaghi estimates that Google generates about $4 billion in ad revenue a year from Maps, with a user base about four times the size, suggesting $1 billion a year in potential ad revenue. And he says that the streaming-device companyRoku (ROKU)provides “a helpful precedent” for how Apple can generate revenue from Apple TV hardware—where he sees another $1 billion-plus opportunity.</p>\n<p>The analyst adds that Apple could place ads on other properties—like Apple Fitness+ and Garage Band—but that the adoption of advertising in applications like Apple Mail, Apple TV+, or Apple’s home screens likely would “irk consumers and undermine Apple’s strongly avowed stance on privacy.”</p>\n<p>Meanwhile, Sacconaghi says, Apple’s position on Identifier for Advertisers, or IDFA, offers the company some competitive advantages. “While we believe that Apple’s move to eliminate IDFA was done in the spirit of advancing consumer privacy, it may ultimately provide Apple with an advertising platform that is competitively advantaged vs. peers who don’t have access to Apple’s richer APIs,” he writes.</p>\n<p>The analyst notes thatAmazon.com‘s (AMZN) ad business was similar in size to Apple’s in 2017—and now has a run rate north of $25 billion and is a substantial part of the investment thesis on the stock. “Along similar lines, a large and growing advertising business could help Apple accelerate its overall Services growth rate, which would likely be viewed positively by investors,” he concludes.</p>\n<p>Apple shares were up 0.1%, at $145.72, in recent trading. TheS&amp;P 500was down fractionally.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Apple’s Advertising Business Is Bigger Than You Think. It Could Get Bigger Still.</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nApple’s Advertising Business Is Bigger Than You Think. It Could Get Bigger Still.\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-08-03 23:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/articles/apples-advertising-business-is-bigger-than-you-think-it-could-get-bigger-still-51628004419?mod=mw_latestnews><strong>MarketWatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted ...</p>\n\n<a href=\"https://www.marketwatch.com/articles/apples-advertising-business-is-bigger-than-you-think-it-could-get-bigger-still-51628004419?mod=mw_latestnews\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.marketwatch.com/articles/apples-advertising-business-is-bigger-than-you-think-it-could-get-bigger-still-51628004419?mod=mw_latestnews","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1171505764","content_text":"Apple’smove to kill off the Identifier for Advertisers system on the iPhone hasinfuriated Facebookand other companies that rely on the ability to track consumer behavior so they can sell targeted advertising.\nThe decision has created the impression that Apple (ticker: AAPL) is simply opposed to digital advertising. But that’s not actually the case. In fact, advertising is gradually becoming a material contributor to the company’s revenue base.\nIn a research note Tuesday, Bernstein analystToni Sacconaghidoes a deep dive into Apple’s ad business. While the company doesn’t talk about the business much andprovides little disclosure, Sacconaghi estimates that Apple will generate about $3 billion in ad revenue in the September 2021 fiscal year, up from about $300 million in fiscal 2017. He thinks the total could grow to the $7 billion-to-$10 billion-a-year range by fiscal 2023 or 2024, boosting growth in Apple’s services business as much as three percentage points.\nSacconaghi notes that most of Apple’s ad business is centered on search ads in the App Store. He says growth drivers in the business include the June addition of search ads in China, higher ad loads, and the introduction of banner ads to the store in May. He also points out that Apple generates modest revenue today—likely under $500 million a year—from ads in the Apple News and Stocks apps.\nThere are other opportunities—including Apple Maps and Apple TV. Sacconaghi estimates that Google generates about $4 billion in ad revenue a year from Maps, with a user base about four times the size, suggesting $1 billion a year in potential ad revenue. And he says that the streaming-device companyRoku (ROKU)provides “a helpful precedent” for how Apple can generate revenue from Apple TV hardware—where he sees another $1 billion-plus opportunity.\nThe analyst adds that Apple could place ads on other properties—like Apple Fitness+ and Garage Band—but that the adoption of advertising in applications like Apple Mail, Apple TV+, or Apple’s home screens likely would “irk consumers and undermine Apple’s strongly avowed stance on privacy.”\nMeanwhile, Sacconaghi says, Apple’s position on Identifier for Advertisers, or IDFA, offers the company some competitive advantages. “While we believe that Apple’s move to eliminate IDFA was done in the spirit of advancing consumer privacy, it may ultimately provide Apple with an advertising platform that is competitively advantaged vs. peers who don’t have access to Apple’s richer APIs,” he writes.\nThe analyst notes thatAmazon.com‘s (AMZN) ad business was similar in size to Apple’s in 2017—and now has a run rate north of $25 billion and is a substantial part of the investment thesis on the stock. “Along similar lines, a large and growing advertising business could help Apple accelerate its overall Services growth rate, which would likely be viewed positively by investors,” he concludes.\nApple shares were up 0.1%, at $145.72, in recent trading. TheS&P 500was down fractionally.","news_type":1},"isVote":1,"tweetType":1,"viewCount":622,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":156665904,"gmtCreate":1625219100108,"gmtModify":1703738601929,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Mehhhh","listText":"Mehhhh","text":"Mehhhh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/156665904","repostId":"1107527256","repostType":4,"isVote":1,"tweetType":1,"viewCount":118,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":140540351,"gmtCreate":1625667031373,"gmtModify":1703746035667,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Didi downdown","listText":"Didi downdown","text":"Didi downdown","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/140540351","repostId":"2149390009","repostType":2,"isVote":1,"tweetType":1,"viewCount":552,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":110595177,"gmtCreate":1622467195299,"gmtModify":1704184810373,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Coinbase!","listText":"Coinbase!","text":"Coinbase!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/110595177","repostId":"2139043042","repostType":4,"repost":{"id":"2139043042","pubTimestamp":1622465643,"share":"https://ttm.financial/m/news/2139043042?lang=&edition=fundamental","pubTime":"2021-05-31 20:54","market":"us","language":"en","title":"Better Buy: Coinbase Stock or Every Nasdaq Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2139043042","media":"Motley Fool","summary":"A pure-play crypto stock or the entire tech index? Read more to find out.","content":"<p>In what seems like the early innings of a crypto revolution, many people wonder what's the best way to get exposure to the segment. Buying <b>Bitcoin</b> (CRYPTO:BTC) directly may seem like a hassle to some amid the various decisions -- how to buy it, where to buy it, and how to store it. Buying a proxy company -- a company that's essentially in the business of Bitcoin -- is often seen as a reasonable solution.</p>\n<p>Enter <b>Coinbase</b> (NASDAQ:COIN). The company went public only a few months ago, initially jumping to over $400 a share before plunging down to around $250 where it currently trades. It's worth considering whether Coinbase is a long-term buy and hold or if you're better off simply buying the Nasdaq stock market index as a whole. For simplicity, we'll use the <b>Nasdaq 100 ETF</b> (NASDAQ:QQQ) for comparison in hopes of finding the better buy.</p>\n<h2>A brief look at Coinbase</h2>\n<p>Coinbase occupies a unique position within the cryptocurrency ecosystem: It's a centralized exchange for Bitcoin transactions. While continued adoption of Bitcoin and other cryptos will undoubtedly help drive revenue, Coinbase will make money as long as people are trading -- which tends to happen more when Bitcoin surges. This method of extracting value from the crypto economy makes sense when you consider the stability of its revenue stream, especially if you're bullish on Bitcoin.</p>\n<p>Coinbase is attractive if you want exposure to cryptocurrency without having to buy it directly -- it's seen as a \"proxy bet\" on cryptocurrency. Further, there are still big questions about wallet and password security, and many investors feel more comfortable buying a listed stock than they do buying digital currency.</p>\n<p>But as with any single stock purchase, you'll be exposed to <i>idiosyncratic risk</i>, or company-specific risk. Anything adverse that could happen to Coinbase is your risk to bear -- lawsuits, accounting scandals, currency failures, you name it. Unsystematic risk is something you should definitely consider before buying any individual stock, but particularly <a href=\"https://laohu8.com/S/AONE\">one</a> with a highly speculative future dependent on emerging technology.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/ce2922a67b338bce7cca59360c150ff5\" tg-width=\"700\" tg-height=\"399\"><span>Image Source: Getty Images.</span></p>\n<h2>The Nasdaq as a whole</h2>\n<p>The Nasdaq exchange has a high concentration of technology stocks and includes Coinbase as <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the 2,500 stocks in its cap-weighted population.&nbsp; The clear benefit to investing in a Nasdaq-mimicking exchange-traded fund (ETF), like the <b>Invesco QQQ Trust</b>, for example, is that you're investing with far less risk. If something unfortunate happens to one of the portfolio constituents, you're insulated by virtue of holding many other great companies at the same time.</p>\n<p>Let's look at what you get when you invest in the Nasdaq index:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/46466f58cfab8acefc0fbfc8a4742b43\" tg-width=\"1153\" tg-height=\"408\"><span>Note: Data current as of May 27, 2021.</span></p>\n<p>While you'll note that the five-year performance numbers of top Nasdaq stocks have been pretty stellar, we aren't interested in past performance when deciding to buy -- we're interested in the potential for <i>consistent future</i> <i>performance</i>. The good news is that many of the same competitive advantages that got these companies to where they are still exist today. By buying the index as a whole, you'll have access to all of the top dogs.</p>\n<h2>The verdict</h2>\n<p>Any time you pit a single stock against an index, almost anyone can make the case that the single stock has greater upside potential because you probably won't see an index double or triple in a single year. Coinbase may very well double its value by 2022, minting new crypto-millionaires.</p>\n<p>But what if that doesn't happen? You need to consider the downside risk present when investing in an innovative technology (like cryptocurrency) that already has significant earnings growth priced in. Given the quality of the companies leading the Nasdaq, it's a more prudent bet to go for the basket of tried-and-true winners as opposed to a potentially volatile wild card.</p>\n<p>With all of that said, a small allocation to Coinbase can make sense if you have interest in the crypto space but don't feel the need or desire to own digital currency directly. For a long-term investor who's serious about keeping their retirement savings, however, the more diversified nature of the Nasdaq index makes it a better buy.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Better Buy: Coinbase Stock or Every Nasdaq Stock?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBetter Buy: Coinbase Stock or Every Nasdaq Stock?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-05-31 20:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/05/31/better-buy-coinbase-stock-or-every-nasdaq-stock/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>In what seems like the early innings of a crypto revolution, many people wonder what's the best way to get exposure to the segment. Buying Bitcoin (CRYPTO:BTC) directly may seem like a hassle to some ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/05/31/better-buy-coinbase-stock-or-every-nasdaq-stock/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite","QLD":"纳指两倍做多ETF","PSQ":"纳指反向ETF","TQQQ":"纳指三倍做多ETF","QID":"纳指两倍做空ETF","QQQ":"纳指100ETF","NDAQ":"纳斯达克OMX交易所","SQQQ":"纳指三倍做空ETF"},"source_url":"https://www.fool.com/investing/2021/05/31/better-buy-coinbase-stock-or-every-nasdaq-stock/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2139043042","content_text":"In what seems like the early innings of a crypto revolution, many people wonder what's the best way to get exposure to the segment. Buying Bitcoin (CRYPTO:BTC) directly may seem like a hassle to some amid the various decisions -- how to buy it, where to buy it, and how to store it. Buying a proxy company -- a company that's essentially in the business of Bitcoin -- is often seen as a reasonable solution.\nEnter Coinbase (NASDAQ:COIN). The company went public only a few months ago, initially jumping to over $400 a share before plunging down to around $250 where it currently trades. It's worth considering whether Coinbase is a long-term buy and hold or if you're better off simply buying the Nasdaq stock market index as a whole. For simplicity, we'll use the Nasdaq 100 ETF (NASDAQ:QQQ) for comparison in hopes of finding the better buy.\nA brief look at Coinbase\nCoinbase occupies a unique position within the cryptocurrency ecosystem: It's a centralized exchange for Bitcoin transactions. While continued adoption of Bitcoin and other cryptos will undoubtedly help drive revenue, Coinbase will make money as long as people are trading -- which tends to happen more when Bitcoin surges. This method of extracting value from the crypto economy makes sense when you consider the stability of its revenue stream, especially if you're bullish on Bitcoin.\nCoinbase is attractive if you want exposure to cryptocurrency without having to buy it directly -- it's seen as a \"proxy bet\" on cryptocurrency. Further, there are still big questions about wallet and password security, and many investors feel more comfortable buying a listed stock than they do buying digital currency.\nBut as with any single stock purchase, you'll be exposed to idiosyncratic risk, or company-specific risk. Anything adverse that could happen to Coinbase is your risk to bear -- lawsuits, accounting scandals, currency failures, you name it. Unsystematic risk is something you should definitely consider before buying any individual stock, but particularly one with a highly speculative future dependent on emerging technology.\nImage Source: Getty Images.\nThe Nasdaq as a whole\nThe Nasdaq exchange has a high concentration of technology stocks and includes Coinbase as one of the 2,500 stocks in its cap-weighted population.  The clear benefit to investing in a Nasdaq-mimicking exchange-traded fund (ETF), like the Invesco QQQ Trust, for example, is that you're investing with far less risk. If something unfortunate happens to one of the portfolio constituents, you're insulated by virtue of holding many other great companies at the same time.\nLet's look at what you get when you invest in the Nasdaq index:\nNote: Data current as of May 27, 2021.\nWhile you'll note that the five-year performance numbers of top Nasdaq stocks have been pretty stellar, we aren't interested in past performance when deciding to buy -- we're interested in the potential for consistent future performance. The good news is that many of the same competitive advantages that got these companies to where they are still exist today. By buying the index as a whole, you'll have access to all of the top dogs.\nThe verdict\nAny time you pit a single stock against an index, almost anyone can make the case that the single stock has greater upside potential because you probably won't see an index double or triple in a single year. Coinbase may very well double its value by 2022, minting new crypto-millionaires.\nBut what if that doesn't happen? You need to consider the downside risk present when investing in an innovative technology (like cryptocurrency) that already has significant earnings growth priced in. Given the quality of the companies leading the Nasdaq, it's a more prudent bet to go for the basket of tried-and-true winners as opposed to a potentially volatile wild card.\nWith all of that said, a small allocation to Coinbase can make sense if you have interest in the crypto space but don't feel the need or desire to own digital currency directly. For a long-term investor who's serious about keeping their retirement savings, however, the more diversified nature of the Nasdaq index makes it a better buy.","news_type":1},"isVote":1,"tweetType":1,"viewCount":57,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":174427485,"gmtCreate":1627130218547,"gmtModify":1703484628900,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Uhoh","listText":"Uhoh","text":"Uhoh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/174427485","repostId":"2153938547","repostType":4,"isVote":1,"tweetType":1,"viewCount":569,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":176895910,"gmtCreate":1626875307930,"gmtModify":1703479722981,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Up up up","listText":"Up up up","text":"Up up up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/176895910","repostId":"1139204971","repostType":4,"isVote":1,"tweetType":1,"viewCount":440,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":157682904,"gmtCreate":1625580434208,"gmtModify":1703744286988,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Oh","listText":"Oh","text":"Oh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/157682904","repostId":"1118465420","repostType":4,"repost":{"id":"1118465420","pubTimestamp":1625580135,"share":"https://ttm.financial/m/news/1118465420?lang=&edition=fundamental","pubTime":"2021-07-06 22:02","market":"us","language":"en","title":"Advaxis Jumps on Deal to Be Bought by Biosight","url":"https://stock-news.laohu8.com/highlight/detail?id=1118465420","media":"Thestreet","summary":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Bi","content":"<p>Advaxis&nbsp;(<b>ADXS</b>)&nbsp;shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.</p>\n<p>At closing, Biosight holders will own 75%&nbsp;of the company and&nbsp;Advaxis holders will own 25%.</p>\n<p>Advaxis,&nbsp;Princeton, N.J.,&nbsp;recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.</p>\n<p>The combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.</p>\n<p>“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.</p>\n<p>The new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.</p>\n<p>In other healthcare news, Iterum Therapeutics&nbsp;(<b>ITRM</b>) -Get Report&nbsp;said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections&nbsp;were found.</p>\n<p>The Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.</p>\n<p>Also last week,Anavex Life Sciences&nbsp;(<b>AVXL</b>) -Get Report&nbsp;reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.</p>\n<p>JonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Advaxis Jumps on Deal to Be Bought by Biosight</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdvaxis Jumps on Deal to Be Bought by Biosight\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-06 22:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock><strong>Thestreet</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and ...</p>\n\n<a href=\"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ADXS":"Ayala Pharmaceuticals, Inc."},"source_url":"https://www.thestreet.com/investing/advaxis-to-be-bought-by-biosight-of-israel-for-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1118465420","content_text":"Advaxis (ADXS) shares were higher Monday after the company agreed to be purchased by peer biotech Biosight of Lod, Israel, for stock.\nAt closing, Biosight holders will own 75% of the company and Advaxis holders will own 25%.\nAdvaxis, Princeton, N.J., recently traded at 70 cents a share, up 48%. It had gained 5% in the six months through Friday.\nThe combined company will be named Biosight Therapeutics and trade on Nasdaq with the ticker symbol BSTX.\n“The proposed merger will create a public company that will prioritize the clinical advancement and commercialization of Biosight’s lead product, aspacytarabine,” the companies said. That drug treats acute myeloid leukemia.\nThe new company is expected to have some $50 million cash, cash equivalents and marketable securities. The deal is expected to close in the second half, subject to conditions including regulatory clearances and votes of holders of both companies.\nIn other healthcare news, Iterum Therapeutics (ITRM) -Get Report said Friday that it received a letterfrom the FDA saying that deficiencies in its treatment for urinary-tract infections were found.\nThe Food and Drug Administration letter stated that as “part of their ongoing review of the company’s new drug application for sulopenem etzadroxil/probenecid, the agency has identified deficiencies that preclude the continuation of the discussion of labeling and post-marketing requirements/commitments at this time,” Iterum said.\nAlso last week,Anavex Life Sciences (AVXL) -Get Report reported progress in a Phase 2 trial of a Parkinson’s drug, Anavex2-73.\nJonesTrading analyst Soumit Roy raised his price target on the New York company to $50 from $35, affirming a buy rating.","news_type":1},"isVote":1,"tweetType":1,"viewCount":181,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":122601603,"gmtCreate":1624614282702,"gmtModify":1703841754005,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"JP Morgan is bullish on what positions they have&nbsp;","listText":"JP Morgan is bullish on what positions they have&nbsp;","text":"JP Morgan is bullish on what positions they have","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/122601603","repostId":"1168965172","repostType":4,"repost":{"id":"1168965172","pubTimestamp":1624613179,"share":"https://ttm.financial/m/news/1168965172?lang=&edition=fundamental","pubTime":"2021-06-25 17:26","market":"us","language":"en","title":"JPMorgan is ‘very bullish’ on 12 global stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1168965172","media":"cnbc","summary":"JPMorgansays the next leg higher in equities is here as its analysts pick the global stocks to ride ","content":"<div>\n<p>JPMorgansays the next leg higher in equities is here as its analysts pick the global stocks to ride it. The bank’s analysts said they “hold a very bullish call on earnings for this year” in a note ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/24/jpmorgan-is-very-bullish-on-these-stock-picks.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JPMorgan is ‘very bullish’ on 12 global stocks</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJPMorgan is ‘very bullish’ on 12 global stocks\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-25 17:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/24/jpmorgan-is-very-bullish-on-these-stock-picks.html><strong>cnbc</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>JPMorgansays the next leg higher in equities is here as its analysts pick the global stocks to ride it. The bank’s analysts said they “hold a very bullish call on earnings for this year” in a note ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/24/jpmorgan-is-very-bullish-on-these-stock-picks.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MG":"Mistras Group","AMSYF":"ArcelorMittal","JFHHF":"Jupiter Fund Management Ltd.","RXLSF":"Rexel SA","VLVLY":"Volvo AB","0J6Y.UK":"法国兴业银行","0HB5.UK":"法国巴黎银行","COD.UK":"SAINT GOBAIN OR","RXEEY":"Rexel SA","EDPFY":"EDP Energias de Portugal SA","BARC.UK":"巴克莱银行"},"source_url":"https://www.cnbc.com/2021/06/24/jpmorgan-is-very-bullish-on-these-stock-picks.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1168965172","content_text":"JPMorgansays the next leg higher in equities is here as its analysts pick the global stocks to ride it. The bank’s analysts said they “hold a very bullish call on earnings for this year” in a note published Monday, and listed their top global picks across a variety of sectors.\nThe analysts, led by JPMorgan’s Mislav Matejka, noted “substantial increases” in 2021 earnings per share (EPS) projections — a key indicator of a company’s profitability— for so-called cyclical stocks and said this trend looked set to continue. Cyclical stocks are those that tend to track the economy’s overall performance.\n“We believe that the next leg higher in equities is upon us,” they added.\nHere are a dozen of their top picks across Europe:\nFinancials\nJPMorgan likes British firms Barclays, M&G and Jupiter, as well as French companies Societe Generaleand BNP Paribas. Also on its list is Dutch firmING, and JPM is overweight all of the stocks. “Sector looks cheap, has underperformed, earnings are improving and stands to benefit from rising bond yields,” the bank’s analysts stated.\nUtilities\nThey also like electricity firms Enel and EDP, and are overweight-rated on the sector as a whole.\nMaterials and industrials\nThe bank’s picks include steel firm Arcelor Mittal, auto maker Volvo, construction materials firm Saint Gobain and electrical supplier Rexel, all of which are rated overweight.\n‘An opportunity’\nJPMorgan’s analysts noted that earnings per share “momentum” was likely reaching a peak, however this should not be negative for stocks. “Activity is expected to remain significantly above trend for the foreseeable future. This could ensure that forward earnings projections keep advancing, and that EPS revisions do not move back persistently into negative territory,” they wrote.\nThere is a widening gap between earnings between cyclicals and defensives — defensives tend to provide consistent earnings regardless of the market in general — with cyclical stocks “overwhelmingly” outperforming defensives, JPMorgan said. And the bank’s analysts think the gap will remain wide: “We do not expect the gap to close through forward earnings of Cyclicals peaking, especially not while the growth delivery is substantially above trend,” the analysts stated.\n“Therefore, this could be an opportunity, in particular if we get a resumption of the upmove in bond yields in 2H [second half],” they added. Investors often expect stock prices to fall when bond yields rise.\n“Regionally, we expect the outperformance of Eurozone vs the US so far this year to continue, in contrast to last year, when we were OW [overweight] US vs Europe,” the analysts added.","news_type":1},"isVote":1,"tweetType":1,"viewCount":63,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":108935772,"gmtCreate":1619974694897,"gmtModify":1704336907944,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Ooosh!","listText":"Ooosh!","text":"Ooosh!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/108935772","repostId":"2132603015","repostType":4,"repost":{"id":"2132603015","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1619872075,"share":"https://ttm.financial/m/news/2132603015?lang=&edition=fundamental","pubTime":"2021-05-01 20:27","market":"us","language":"en","title":"Berkshire Hathaway Q1 Earnings Here！","url":"https://stock-news.laohu8.com/highlight/detail?id=2132603015","media":"Reuters","summary":"May 1 (Reuters) - Berkshire Hathaway Inc   :Full report here！* Q1 NET EARNINGS ATTRIBUTABLE TO BERKS","content":"<p>May 1 (Reuters) - Berkshire Hathaway Inc   :</p><p><a href=\"https://www.berkshirehathaway.com/qtrly/1stqtr21.pdf\" target=\"_blank\">Full report here！</a></p><p>* Q1 NET EARNINGS ATTRIBUTABLE TO BERKSHIRE SHAREHOLDERS $11.71 BILLION VERSUS YEAR-EARLIER $49.75 BILLION LOSS</p><p>* Q1 OPERATING EARNINGS $7.02 BILLION VERSUS $5.87 BILLION</p><p>* Q1 NET EARNINGS PER AVERAGE EQUIVALENT CLASS A SHARE $7,638</p><p>* Q1 NET EARNINGS FROM INVESTMENT AND DERIVATIVE GAINS $4.69 BILLION VERSUS YEAR-EARLIER $55.62 BILLION NET LOSS</p><p>* AT MARCH 31, 2021, INSURANCE FLOAT WAS ABOUT $140 BILLION, INCREASE OF ABOUT $2 BILLION SINCE YEAREND 2020</p><p>* ABOUT $6.6 BILLION WAS USED TO PURCHASE SHARES OF CLASS A AND CLASS B COMMON STOCK DURING THE FIRST QUARTER OF 2021</p><p>Source text for Eikon:    Further company coverage:</p><p><a href=\"https://www.berkshirehathaway.com/qtrly/1stqtr21.pdf\" target=\"_blank\">Full article of Berkshire Hathaway Q1 report</a></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Berkshire Hathaway Q1 Earnings Here！</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBerkshire Hathaway Q1 Earnings Here！\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-05-01 20:27</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>May 1 (Reuters) - Berkshire Hathaway Inc   :</p><p><a href=\"https://www.berkshirehathaway.com/qtrly/1stqtr21.pdf\" target=\"_blank\">Full report here！</a></p><p>* Q1 NET EARNINGS ATTRIBUTABLE TO BERKSHIRE SHAREHOLDERS $11.71 BILLION VERSUS YEAR-EARLIER $49.75 BILLION LOSS</p><p>* Q1 OPERATING EARNINGS $7.02 BILLION VERSUS $5.87 BILLION</p><p>* Q1 NET EARNINGS PER AVERAGE EQUIVALENT CLASS A SHARE $7,638</p><p>* Q1 NET EARNINGS FROM INVESTMENT AND DERIVATIVE GAINS $4.69 BILLION VERSUS YEAR-EARLIER $55.62 BILLION NET LOSS</p><p>* AT MARCH 31, 2021, INSURANCE FLOAT WAS ABOUT $140 BILLION, INCREASE OF ABOUT $2 BILLION SINCE YEAREND 2020</p><p>* ABOUT $6.6 BILLION WAS USED TO PURCHASE SHARES OF CLASS A AND CLASS B COMMON STOCK DURING THE FIRST QUARTER OF 2021</p><p>Source text for Eikon:    Further company coverage:</p><p><a href=\"https://www.berkshirehathaway.com/qtrly/1stqtr21.pdf\" target=\"_blank\">Full article of Berkshire Hathaway Q1 report</a></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BRK.B":"伯克希尔B","BRK.A":"伯克希尔"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2132603015","content_text":"May 1 (Reuters) - Berkshire Hathaway Inc   :Full report here！* Q1 NET EARNINGS ATTRIBUTABLE TO BERKSHIRE SHAREHOLDERS $11.71 BILLION VERSUS YEAR-EARLIER $49.75 BILLION LOSS* Q1 OPERATING EARNINGS $7.02 BILLION VERSUS $5.87 BILLION* Q1 NET EARNINGS PER AVERAGE EQUIVALENT CLASS A SHARE $7,638* Q1 NET EARNINGS FROM INVESTMENT AND DERIVATIVE GAINS $4.69 BILLION VERSUS YEAR-EARLIER $55.62 BILLION NET LOSS* AT MARCH 31, 2021, INSURANCE FLOAT WAS ABOUT $140 BILLION, INCREASE OF ABOUT $2 BILLION SINCE YEAREND 2020* ABOUT $6.6 BILLION WAS USED TO PURCHASE SHARES OF CLASS A AND CLASS B COMMON STOCK DURING THE FIRST QUARTER OF 2021Source text for Eikon:    Further company coverage:Full article of Berkshire Hathaway Q1 report","news_type":1},"isVote":1,"tweetType":1,"viewCount":64,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":159279501,"gmtCreate":1624972634803,"gmtModify":1703849116911,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>Not so magical after all :(","listText":"<a href=\"https://laohu8.com/S/DIS\">$Walt Disney(DIS)$</a>Not so magical after all :(","text":"$Walt Disney(DIS)$Not so magical after all :(","images":[{"img":"https://static.tigerbbs.com/c2908737f01d2968c4d89244e68b3844","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/159279501","isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":122608210,"gmtCreate":1624614322730,"gmtModify":1703841757912,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>Still so far away ?","listText":"<a href=\"https://laohu8.com/S/GOTU\">$Gaotu Techedu Inc.(GOTU)$</a>Still so far away ?","text":"$Gaotu Techedu Inc.(GOTU)$Still so far away ?","images":[{"img":"https://static.tigerbbs.com/c073bfa00121dcf1742af04ee9ae2d1d","width":"1125","height":"1949"}],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/122608210","isVote":1,"tweetType":1,"viewCount":138,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":1,"langContent":"EN","totalScore":0},{"id":126916404,"gmtCreate":1624542006608,"gmtModify":1703839816316,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Time for tech to bounce back!!!!!!!! Like andcomment please&nbsp;","listText":"Time for tech to bounce back!!!!!!!! Like andcomment please&nbsp;","text":"Time for tech to bounce back!!!!!!!! Like andcomment please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/126916404","repostId":"2145046194","repostType":4,"repost":{"id":"2145046194","pubTimestamp":1624540200,"share":"https://ttm.financial/m/news/2145046194?lang=&edition=fundamental","pubTime":"2021-06-24 21:10","market":"us","language":"en","title":"3 Tech Stocks with 35% to 54% Upside, According to Wall Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2145046194","media":"Motley Fool","summary":"Talking heads like to point to \"expensive\" tech stocks, but analysts think these technology names are still materially undervalued.","content":"<p>Investors appear to have soured on tech stocks over the last few months. The prospect of higher inflation and a rotation to cheaper \"reopening\" plays have certainly hurt some of the very stocks that have powered the market's gains over the past few years.</p>\n<p>But digital trends aren't going away with the reopening, so if the world goes back to a pre-pandemic \"normal,\" it's reasonable to expect that technology stocks will eventually gain some market leadership and continue their strong relative performance. Today, Wall Street analysts see larger-than-average gains between 35% and 54% for the stocks of <b>Alteryx</b> (NYSE:AYX), <b>Uber Technologies</b> (NYSE:UBER), and <b>Micron Technology</b> (NASDAQ:MU).</p>\n<p><img src=\"https://static.tigerbbs.com/1459afd2cda964bb91343031338eaea0\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>Alteryx: Implied upside of 35%</h3>\n<p>Data analytics software company Alteryx has not only seen its shares fall with its peer group in 2021, but it actually underperformed the sector in 2020 as well. Currently, the stock is down more than 50% from the all-time highs set back in July 2020, and it trades at just 11 times sales, a discount to most of its peers in the SaaS sector.</p>\n<p>There are a couple of reasons for Alteryx's relative underperformance. First, it has to use a strange accounting convention, whereby it recognizes 35%-40% of its contract value upfront, with the rest recognized ratably over time. That can really distort things when new business slows down, or when contract terms compress. That happened with the onset of the pandemic, so it appeared that Alteryx's revenue had plunged. However, its customer growth and annual recurring revenue (ARR), which aren't affected by accounting conventions, showed much stronger growth this past year:</p>\n<table>\n <thead>\n  <tr>\n   <th><p><b>Alteryx</b></p></th>\n   <th><p><b>Q1 2020</b></p></th>\n   <th><p><b>Q2 2020</b></p></th>\n   <th><p><b>Q3 2020</b></p></th>\n   <th><p><b>Q4 2020</b></p></th>\n   <th><p><b>Q1 2021</b></p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td width=\"104\"><p>Revenue growth (YOY)</p></td>\n   <td width=\"104\"><p>43%</p></td>\n   <td width=\"104\"><p>17%</p></td>\n   <td width=\"104\"><p>25%</p></td>\n   <td width=\"104\"><p>3%</p></td>\n   <td width=\"104\"><p>9%</p></td>\n  </tr>\n  <tr>\n   <td width=\"104\"><p>ARR growth (YOY)</p></td>\n   <td width=\"104\"><p>N/A</p></td>\n   <td width=\"104\"><p>40%</p></td>\n   <td width=\"104\"><p>38%</p></td>\n   <td width=\"104\"><p>32%</p></td>\n   <td width=\"104\"><p>27%</p></td>\n  </tr>\n  <tr>\n   <td width=\"104\"><p>Customer growth (YOY)</p></td>\n   <td width=\"104\"><p>30%</p></td>\n   <td width=\"104\"><p>27%</p></td>\n   <td width=\"104\"><p>24%</p></td>\n   <td width=\"104\"><p>16%</p></td>\n   <td width=\"104\"><p>12%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Alteryx earnings transcripts. YOY = year over year.</p>\n<p>While there is some deceleration, it's somewhat inevitable that a company will decelerate as it grows. Moreover, new CEO Mark Anderson, who took over in late 2020, is fairly new to the job. He has taken a more focused approach to sales and marketing, concentrating Alteryx's efforts on the largest global companies with more capacity to spend. So that could be why the customer count is slowing -- Alteryx is implementing a strategy of getting its best customers to spend more. On the recent conference call with analysts, Anderson reiterated that he sees \"new and significant expansion opportunities,\" just within the Global 2000 large-cap companies, where Alteryx only has 39% penetration.</p>\n<p>Wall Street analysts appear to believe in Anderson, who has a track record of scaling software businesses, most recently at <b><a href=\"https://laohu8.com/S/PANW\">Palo Alto Networks</a></b> (NYSE:PANW). The average target among 14 analysts who cover Alteryx stock is $117.71, about 35% upside from current levels.</p>\n<h3>Uber Technologies: Implied upside of 40%</h3>\n<p>With the economic reopening at hand, analysts are also warming up to the world's leading ride-hailing business, Uber Technologies. Obviously, Uber's core ride-hailing business took a big hit during the pandemic; however, the company was able to maintain some level of revenue stability thanks to its food delivery business, which skyrocketed with people stuck at home.</p>\n<p>Food delivery revenue rose 230% last quarter, helped out by the December acquisition of Postmates and helping to offset a 41% year-over-year decline in mobility revenue. Last quarter, food delivery was actually the largest segment by revenue for the first time. Helped out by increased operating leverage, higher take rates, and cost cuts following the Postmates acquisition, Uber's food delivery platform saw adjusted EBITDA losses narrow from $313 million to $200 million last quarter. On the conference call with analysts, CEO Dara Khosrowshahi said he expects EBITDA breakeven for the delivery business by year end. The freight business also continued to grow nicely, with revenue up 51% and EBITDA losses improving by 55%.</p>\n<p>Uber has also been streamlining its business, selling off its autonomous vehicle and flying car divisions to start-ups, and management expects the streamlining of the business will lead to profitability in the near term -- at least on an adjusted EBITDA basis.</p>\n<p>The ideal scenario would be for food delivery revenue to stick around due to new habits and work-from-anywhere cultures, with ride-sharing bouncing back strongly and the freight business scaling. Analysts appear to share the sunny outlook, with the average price target among 38 analysts at $68.64, about 40% above current stock levels.</p>\n<h3>Micron Technology: Implied upside of 53.6%</h3>\n<p>Finally, memory chip maker Micron Technology also has lots of upside, according to Wall Street analysts. It may be surprising that Micron is down some 21% from all-time highs, given that memory prices have been rising amid a big chip shortage. Perhaps Micron's participation in the technology sector has contributed to the skepticism.</p>\n<p>What's strange is that Micron, unlike a lot of high-growth software stocks, is really more like a cyclical stock, and appears set for higher profits throughout 2021 and into 2022. In fact, the stock only trades at a mere 7.5 times next year's earnings estimates. Micron has also committed to return at least 50% of free cash flow to shareholders via share repurchases, so the company will likely take advantage of the currently discounted stock price by buying back stock.</p>\n<p>Of course, Micron's share price is quite volatile, so investors should be prepared. Some analysts appear to be looking for the next down cycle, as Micron tends to boom and bust based on memory prices. In fact, <a href=\"https://laohu8.com/S/AONE\">one</a> analyst at Lynx Equity Strategies just downgraded Micron to a sell rating based on the anticipation of memory price slowdowns in the back half of the year; but strangely, that same analyst lowered his price target from $110 to $100, still about 30% higher than today's stock price!</p>\n<p>Fears of a downturn seem a bit premature to me, since memory cycles tend to last a couple years, not just two good quarters. Micron remained profitable in the recent downturn, and could potentially make higher highs in this up cycle. Meanwhile, memory-intensive digitization trends around 5G, AI, and the Internet of Things accelerated during the pandemic, which I wouldn't expect to slow down any time soon.</p>\n<p>Most analysts appear to have a more bullish outlook, with the average price target among 30 analysts covering the stock at $118.62, about 53% higher than the price today. In fact, even the lowest analyst price target is $90, about 18% higher than the current stock price, and the highest price target is $172. With a single-digit P/E ratio and that kind of discount, Micron looks like an intriguing tech play for value investors.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Tech Stocks with 35% to 54% Upside, According to Wall Street</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Tech Stocks with 35% to 54% Upside, According to Wall Street\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-24 21:10 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/06/24/3-tech-stocks-with-35-to-54-upside/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Investors appear to have soured on tech stocks over the last few months. The prospect of higher inflation and a rotation to cheaper \"reopening\" plays have certainly hurt some of the very stocks that ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/06/24/3-tech-stocks-with-35-to-54-upside/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"UBER":"优步","MU":"美光科技","AYX":"Alteryx Inc."},"source_url":"https://www.fool.com/investing/2021/06/24/3-tech-stocks-with-35-to-54-upside/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2145046194","content_text":"Investors appear to have soured on tech stocks over the last few months. The prospect of higher inflation and a rotation to cheaper \"reopening\" plays have certainly hurt some of the very stocks that have powered the market's gains over the past few years.\nBut digital trends aren't going away with the reopening, so if the world goes back to a pre-pandemic \"normal,\" it's reasonable to expect that technology stocks will eventually gain some market leadership and continue their strong relative performance. Today, Wall Street analysts see larger-than-average gains between 35% and 54% for the stocks of Alteryx (NYSE:AYX), Uber Technologies (NYSE:UBER), and Micron Technology (NASDAQ:MU).\n\nImage source: Getty Images.\nAlteryx: Implied upside of 35%\nData analytics software company Alteryx has not only seen its shares fall with its peer group in 2021, but it actually underperformed the sector in 2020 as well. Currently, the stock is down more than 50% from the all-time highs set back in July 2020, and it trades at just 11 times sales, a discount to most of its peers in the SaaS sector.\nThere are a couple of reasons for Alteryx's relative underperformance. First, it has to use a strange accounting convention, whereby it recognizes 35%-40% of its contract value upfront, with the rest recognized ratably over time. That can really distort things when new business slows down, or when contract terms compress. That happened with the onset of the pandemic, so it appeared that Alteryx's revenue had plunged. However, its customer growth and annual recurring revenue (ARR), which aren't affected by accounting conventions, showed much stronger growth this past year:\n\n\n\nAlteryx\nQ1 2020\nQ2 2020\nQ3 2020\nQ4 2020\nQ1 2021\n\n\n\n\nRevenue growth (YOY)\n43%\n17%\n25%\n3%\n9%\n\n\nARR growth (YOY)\nN/A\n40%\n38%\n32%\n27%\n\n\nCustomer growth (YOY)\n30%\n27%\n24%\n16%\n12%\n\n\n\nData source: Alteryx earnings transcripts. YOY = year over year.\nWhile there is some deceleration, it's somewhat inevitable that a company will decelerate as it grows. Moreover, new CEO Mark Anderson, who took over in late 2020, is fairly new to the job. He has taken a more focused approach to sales and marketing, concentrating Alteryx's efforts on the largest global companies with more capacity to spend. So that could be why the customer count is slowing -- Alteryx is implementing a strategy of getting its best customers to spend more. On the recent conference call with analysts, Anderson reiterated that he sees \"new and significant expansion opportunities,\" just within the Global 2000 large-cap companies, where Alteryx only has 39% penetration.\nWall Street analysts appear to believe in Anderson, who has a track record of scaling software businesses, most recently at Palo Alto Networks (NYSE:PANW). The average target among 14 analysts who cover Alteryx stock is $117.71, about 35% upside from current levels.\nUber Technologies: Implied upside of 40%\nWith the economic reopening at hand, analysts are also warming up to the world's leading ride-hailing business, Uber Technologies. Obviously, Uber's core ride-hailing business took a big hit during the pandemic; however, the company was able to maintain some level of revenue stability thanks to its food delivery business, which skyrocketed with people stuck at home.\nFood delivery revenue rose 230% last quarter, helped out by the December acquisition of Postmates and helping to offset a 41% year-over-year decline in mobility revenue. Last quarter, food delivery was actually the largest segment by revenue for the first time. Helped out by increased operating leverage, higher take rates, and cost cuts following the Postmates acquisition, Uber's food delivery platform saw adjusted EBITDA losses narrow from $313 million to $200 million last quarter. On the conference call with analysts, CEO Dara Khosrowshahi said he expects EBITDA breakeven for the delivery business by year end. The freight business also continued to grow nicely, with revenue up 51% and EBITDA losses improving by 55%.\nUber has also been streamlining its business, selling off its autonomous vehicle and flying car divisions to start-ups, and management expects the streamlining of the business will lead to profitability in the near term -- at least on an adjusted EBITDA basis.\nThe ideal scenario would be for food delivery revenue to stick around due to new habits and work-from-anywhere cultures, with ride-sharing bouncing back strongly and the freight business scaling. Analysts appear to share the sunny outlook, with the average price target among 38 analysts at $68.64, about 40% above current stock levels.\nMicron Technology: Implied upside of 53.6%\nFinally, memory chip maker Micron Technology also has lots of upside, according to Wall Street analysts. It may be surprising that Micron is down some 21% from all-time highs, given that memory prices have been rising amid a big chip shortage. Perhaps Micron's participation in the technology sector has contributed to the skepticism.\nWhat's strange is that Micron, unlike a lot of high-growth software stocks, is really more like a cyclical stock, and appears set for higher profits throughout 2021 and into 2022. In fact, the stock only trades at a mere 7.5 times next year's earnings estimates. Micron has also committed to return at least 50% of free cash flow to shareholders via share repurchases, so the company will likely take advantage of the currently discounted stock price by buying back stock.\nOf course, Micron's share price is quite volatile, so investors should be prepared. Some analysts appear to be looking for the next down cycle, as Micron tends to boom and bust based on memory prices. In fact, one analyst at Lynx Equity Strategies just downgraded Micron to a sell rating based on the anticipation of memory price slowdowns in the back half of the year; but strangely, that same analyst lowered his price target from $110 to $100, still about 30% higher than today's stock price!\nFears of a downturn seem a bit premature to me, since memory cycles tend to last a couple years, not just two good quarters. Micron remained profitable in the recent downturn, and could potentially make higher highs in this up cycle. Meanwhile, memory-intensive digitization trends around 5G, AI, and the Internet of Things accelerated during the pandemic, which I wouldn't expect to slow down any time soon.\nMost analysts appear to have a more bullish outlook, with the average price target among 30 analysts covering the stock at $118.62, about 53% higher than the price today. In fact, even the lowest analyst price target is $90, about 18% higher than the current stock price, and the highest price target is $172. With a single-digit P/E ratio and that kind of discount, Micron looks like an intriguing tech play for value investors.","news_type":1},"isVote":1,"tweetType":1,"viewCount":29,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":166500301,"gmtCreate":1624015082803,"gmtModify":1703826592037,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Would you prefer Ferrari or Lambo?","listText":"Would you prefer Ferrari or Lambo?","text":"Would you prefer Ferrari or Lambo?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/166500301","repostId":"2144773663","repostType":2,"repost":{"id":"2144773663","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1624011577,"share":"https://ttm.financial/m/news/2144773663?lang=&edition=fundamental","pubTime":"2021-06-18 18:19","market":"us","language":"en","title":"Ferrari, Amazon's AWS enter agreement on data","url":"https://stock-news.laohu8.com/highlight/detail?id=2144773663","media":"Reuters","summary":"MILAN, June 18 (Reuters) - Ferrari    and Amazon Web Services $(AWS.SI)$ have entered an agreement t","content":"<html><body><p>MILAN, June 18 (Reuters) - Ferrari    and Amazon Web Services <a href=\"https://laohu8.com/S/AWS.SI\">$(AWS.SI)$</a> have entered an agreement to make Amazon's</p><p>  cloud computing unit the luxury carmaker's cloud storage, machine learning, and artificial intelligence provider, AWS said on Friday.</p><p>   The deal will help Ferrari streamline design and testing of its cars, and allow its Scuderia Ferrari Formula One racing team to launch a digital fan engagement platform, AWS said in a statement.</p><p>   \"Together, the companies will accelerate the pace of innovation across the entire Ferrari organization\", including their road cars department, GT Competitions, the Ferrari Challenge, and the Formula One team, it added.</p><p>   Ferrari will rely on AWS's advanced analytics, machine learning, compute, storage, and database capabilities \"to rapidly achieve insights into car design and performance on the road and track,\" AWS said.</p><p>   Ferrari said in a separate statement that the engagement platform it will with AWS was aimed to increasingly connect Formula One fans with the daily life of its racing team and its drivers, \"through personalisation tools, exclusive content and interactive applications\".</p><p>   Financial details of the deal were not disclosed.</p><p>   As part of the partnership, the AWS logo will appear on Scuderia Ferrari's cars and drivers' apparel starting from the French Grand Prix this weekend, AWS said.</p><p> (Reporting by Giulio Piovaccari, editing by Louise Heavens)</p><p>((giulio.piovaccari@thomsonreuters.com))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ferrari, Amazon's AWS enter agreement on data</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFerrari, Amazon's AWS enter agreement on data\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-06-18 18:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>MILAN, June 18 (Reuters) - Ferrari    and Amazon Web Services <a href=\"https://laohu8.com/S/AWS.SI\">$(AWS.SI)$</a> have entered an agreement to make Amazon's</p><p>  cloud computing unit the luxury carmaker's cloud storage, machine learning, and artificial intelligence provider, AWS said on Friday.</p><p>   The deal will help Ferrari streamline design and testing of its cars, and allow its Scuderia Ferrari Formula One racing team to launch a digital fan engagement platform, AWS said in a statement.</p><p>   \"Together, the companies will accelerate the pace of innovation across the entire Ferrari organization\", including their road cars department, GT Competitions, the Ferrari Challenge, and the Formula One team, it added.</p><p>   Ferrari will rely on AWS's advanced analytics, machine learning, compute, storage, and database capabilities \"to rapidly achieve insights into car design and performance on the road and track,\" AWS said.</p><p>   Ferrari said in a separate statement that the engagement platform it will with AWS was aimed to increasingly connect Formula One fans with the daily life of its racing team and its drivers, \"through personalisation tools, exclusive content and interactive applications\".</p><p>   Financial details of the deal were not disclosed.</p><p>   As part of the partnership, the AWS logo will appear on Scuderia Ferrari's cars and drivers' apparel starting from the French Grand Prix this weekend, AWS said.</p><p> (Reporting by Giulio Piovaccari, editing by Louise Heavens)</p><p>((giulio.piovaccari@thomsonreuters.com))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"09086":"华夏纳指-U","03086":"华夏纳指","QNETCN":"纳斯达克中美互联网老虎指数","AMZN":"亚马逊"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2144773663","content_text":"MILAN, June 18 (Reuters) - Ferrari    and Amazon Web Services $(AWS.SI)$ have entered an agreement to make Amazon's  cloud computing unit the luxury carmaker's cloud storage, machine learning, and artificial intelligence provider, AWS said on Friday.   The deal will help Ferrari streamline design and testing of its cars, and allow its Scuderia Ferrari Formula One racing team to launch a digital fan engagement platform, AWS said in a statement.   \"Together, the companies will accelerate the pace of innovation across the entire Ferrari organization\", including their road cars department, GT Competitions, the Ferrari Challenge, and the Formula One team, it added.   Ferrari will rely on AWS's advanced analytics, machine learning, compute, storage, and database capabilities \"to rapidly achieve insights into car design and performance on the road and track,\" AWS said.   Ferrari said in a separate statement that the engagement platform it will with AWS was aimed to increasingly connect Formula One fans with the daily life of its racing team and its drivers, \"through personalisation tools, exclusive content and interactive applications\".   Financial details of the deal were not disclosed.   As part of the partnership, the AWS logo will appear on Scuderia Ferrari's cars and drivers' apparel starting from the French Grand Prix this weekend, AWS said. (Reporting by Giulio Piovaccari, editing by Louise Heavens)((giulio.piovaccari@thomsonreuters.com))","news_type":1},"isVote":1,"tweetType":1,"viewCount":155,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184566913,"gmtCreate":1623719039832,"gmtModify":1704209413000,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"To newer highs!","listText":"To newer highs!","text":"To newer highs!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/184566913","repostId":"1126626020","repostType":4,"repost":{"id":"1126626020","pubTimestamp":1623710198,"share":"https://ttm.financial/m/news/1126626020?lang=&edition=fundamental","pubTime":"2021-06-15 06:36","market":"us","language":"en","title":"Nasdaq rises to an all-time closing high, S&P 500 ekes out another record","url":"https://stock-news.laohu8.com/highlight/detail?id=1126626020","media":"CNBC","summary":"The Nasdaq Composite jumped to a record high on Monday as investors rotated back into growth-oriented stocks ahead of a key Federal Reserve meeting.The tech-heavy benchmark rose 0.7% to an all-time closing high of 14,174.14, overtaking the previous record on April 26. The S&P 500 gained about 0.2% to another record close 4,255.15, boosted by the technology sector. The Dow Jones Industrial Average slipped 85.85 points, or nearly 0.3%, to 34,393,75.Investors are giving growth and tech stocks anoth","content":"<div>\n<p>The Nasdaq Composite jumped to a record high on Monday as investors rotated back into growth-oriented stocks ahead of a key Federal Reserve meeting.\nThe tech-heavy benchmark rose 0.7% to an all-time ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/13/us-stock-futures-are-flat-with-the-sp-500-at-a-record-high.html\">Web Link</a>\n\n</div>\n","source":"cnbc_highlight","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq rises to an all-time closing high, S&P 500 ekes out another record</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq rises to an all-time closing high, S&P 500 ekes out another record\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-15 06:36 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.cnbc.com/2021/06/13/us-stock-futures-are-flat-with-the-sp-500-at-a-record-high.html><strong>CNBC</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Nasdaq Composite jumped to a record high on Monday as investors rotated back into growth-oriented stocks ahead of a key Federal Reserve meeting.\nThe tech-heavy benchmark rose 0.7% to an all-time ...</p>\n\n<a href=\"https://www.cnbc.com/2021/06/13/us-stock-futures-are-flat-with-the-sp-500-at-a-record-high.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"source_url":"https://www.cnbc.com/2021/06/13/us-stock-futures-are-flat-with-the-sp-500-at-a-record-high.html","is_english":true,"share_image_url":"https://static.laohu8.com/72bb72e1b84c09fca865c6dcb1bbcd16","article_id":"1126626020","content_text":"The Nasdaq Composite jumped to a record high on Monday as investors rotated back into growth-oriented stocks ahead of a key Federal Reserve meeting.\nThe tech-heavy benchmark rose 0.7% to an all-time closing high of 14,174.14, overtaking the previous record on April 26. The S&P 500 gained about 0.2% to another record close 4,255.15, boosted by the technology sector. The Dow Jones Industrial Average slipped 85.85 points, or nearly 0.3%, to 34,393,75.\nInvestors are giving growth and tech stocks another chance as bond yields come down. The 10-year Treasury fell below 1.43% on Friday, a three-month low. Cathie Wood’s Ark Innovation, an ETF that focuses on disruptive technology,returned about 6% last week. The fund rose 1.9% Monday even as the benchmark Treasury yield rose briefly back to 1.5%. Apple and Netflix both jumped more than 2%, while Amazon, Microsoft and Facebook also registered gains.\nBoosting cryptocurrency sentiment, Tesla CEO Elon Musk on Sunday said the company will resume bitcoin transactions once it confirms there is reasonable clean energy usage by miners. Bitcoin recovered back above $40,000 Monday. Tesla, a big holder of bitcoin, climbed nearly 1.3%.\n“The broad market’s modest performance is pretty much in line with historical patterns— specifically, June’s tendency for generally quiet trading,” said Chris Larkin, managing director of trading at E-Trade Financial. “As the market continues to sort through potential moves made by the Fed and looming inflation, we could continue to see this narrative play out in the short-term.”\nThe Fed’s two-day policy meeting will likely dominate investor behavior this week. Although the central bank is not expected to take any action, its forecasts for interest rates, inflation and the economy could move the markets. The Fed could possibly move up its forecast for a rate hike after saying in its last quarterly update that it would keep its benchmark rate near zero through 2023,the Wall Street Journal reported on Monday.\nFed Chairman Jerome Powell will speak to the press after the central bank issues its statement Wednesday. Traders will be parsing his comments for any clues as to when the Fed could start to end its aggressive monthly asset purchases, especially given recent hotter-than-expected inflation readings.\nBillionaire hedge fund manager Paul Tudor Jones said this week’s Fed meeting could be the most important in Powell’s career, and he warned that the chairman could spark a big sell-off in risk assets if he doesn’t do a good job of signaling a taper.\n“If they course correct, if they say, ‘We’ve got incoming data, we’ve accomplished our mission or we’re on the way very rapidly to accomplishing our mission on employment,’ then you’re going to get a taper tantrum,” Tudor Jones said. “You’re going to get a sell-off in fixed income. You’re going to get a correction in stocks.”\nU.S. stocks ended last week with a record closing high for the S&P 500 and the beginning of a rotation back into growth names.\nLast week, the 30-stock Dow Jones Industrial Average fell 0.8%, but the S&P 500 rose 0.4%, for its third straight positive week. The Nasdaq Composite was the outperformer with a gain of nearly 1.9%, posting its fourth winning week in a row as the tech trade came back into favor.","news_type":1},"isVote":1,"tweetType":1,"viewCount":73,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":181761708,"gmtCreate":1623412292104,"gmtModify":1704202892622,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"ARK!","listText":"ARK!","text":"ARK!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/181761708","repostId":"1190309980","repostType":4,"repost":{"id":"1190309980","pubTimestamp":1623411452,"share":"https://ttm.financial/m/news/1190309980?lang=&edition=fundamental","pubTime":"2021-06-11 19:37","market":"us","language":"en","title":"2 Crucial Lessons From Cathie Wood About Apple Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=1190309980","media":"The Street","summary":"Cathie Wood’s ARK Invest is not much of an investor in Apple stock. But the famed fund manager has offered valuable advice about the Cupertino company’s shares that is worth revisiting.In doing my daily research of Apple stock  -Get Report, I stumbled upon a gem from Ark Invest’s CEO, CIO and rockstar money manager Cathie Wood. In January 2016, during aninterviewwith CNBC, she was asked which stock seemed like a better buy at the time: AAPL or AMZN.Considering Apple stock’s loss of 5% in 2015, h","content":"<blockquote>\n <b>Cathie Wood’s ARK Invest is not much of an investor in Apple stock. But the famed fund manager has offered valuable advice about the Cupertino company’s shares that is worth revisiting.</b>\n</blockquote>\n<p>In doing my daily research of Apple stock&nbsp;(<b>AAPL</b>) -Get Report, I stumbled upon a gem from Ark Invest’s CEO, CIO and rockstar money manager Cathie Wood. In January 2016, during aninterviewwith CNBC, she was asked which stock seemed like a better buy at the time: AAPL or AMZN.</p>\n<p>Considering Apple stock’s loss of 5% in 2015, her response was the following:</p>\n<blockquote>\n “At this moment, […] Apple might be, because […] the thinking there is so short term. […] Apple is going to become a big company, and [the stock] has been depressed recently by channel checks: how iPhone sales will do in the first quarter, or in the second quarter.”\n</blockquote>\n<p>Since this interview, Apple share price climbed a whopping 400%-plus in just over five years.</p>\n<p><b>#1. Buying quality on weakness</b></p>\n<p>The first important lesson from Ms. Wood’s 2016 insight above is that high-quality companies, whose stocks are likely to climb over time, should be bought on weakness. The logic is simple: if the long-term trend is up, buy shares when the market is selling them at a discount.</p>\n<p>I put some numbers around this ideaa couple of months ago. Historically, it has made much more sense to buy AAPL when shares declined from a previous peak.</p>\n<p>The chart below shows the historical average one-year return in Apple stock under different scenarios. Notice that, the more shares dip, the higher the future returns have been.</p>\n<p><img src=\"https://static.tigerbbs.com/d8f3b347dced7ad7d67e5c7ef756c550\" tg-width=\"578\" tg-height=\"348\">Following the same logic, current Apple investors might be encouraged that the stock remains under water: 12% below the January 2021 top of $143. Should AAPL make fresh all-time highs soon, asI recently speculated that it could, returns for the remainder of the year may start to look appealing.</p>\n<p><b>#2. Filtering out short-term noise</b></p>\n<p>The second point made by Cathie Wood is at least as important. In her view, Apple stock was under pressure in 2015 and early 2016 due to short-term concerns over smartphone sales in the following couple of quarters, especially after the blockbuster release of the iPhone 6.</p>\n<p>In analyzing market movements, I believe it helps to think about the real drivers of share price: buyers and sellers of the stock. Sometimes, people on both sides of the transaction are more concerned about how a stock might perform in the near term, possibly hoping to make a quick buck – and this is just fine.</p>\n<p>In these cases, long-term buyers are probably better off ignoring “short term noise” about what sales or earnings might look like right around the corner. Better yet, they might want to take advantage of selling pressures created by short-term traders to enter a position at better prices.</p>\n<p>Apple might be faced with a similar setup in 2021. The chatter on Wall Street seems torevolve around the company’s follow throughto a successful pandemic year and launch of the first 5G-capable iPhone.</p>\n<p>But look beyond the next 12 months, and one might find it easier to make a bullish case on Apple stock. The company continues to grow revenues, expand margins, pile on cash, while it has yet to tap intoopportunities in mixed realityandautonomous vehicles.</p>\n<p><b>Twitter speaks</b></p>\n<p>Big Tech stocks like Amazon and Apple are a tiny piece of famed investor Cathie Wood’s ARK portfolios. In your view, which of the following FAAMG names would deserve higher allocation in a tech disrupter and innovator ETF? Leave your vote below on our partner's Twitter, @AmazonMaven.</p>\n<p><img src=\"https://static.tigerbbs.com/565580495c2d16818604c9b6d814b1db\" tg-width=\"582\" tg-height=\"480\"></p>\n<p><b>Is the price right?</b></p>\n<p>Looking at a company’s business fundamentals is only half the work needed to find a good stock. How much one pays to own the shares is a key factor in the success of any investment. This is why valuation analysis is so important.</p>\n<p>Alpha Spread’suser-friendly platform allows you to estimate a stock’s fair value –through valuation multiples, discounted cash flow, and more. I believe that the service is a must for anyone looking to own the right stock at the right price.Check out alphaspread.comand get started with a 7-day free trial.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Crucial Lessons From Cathie Wood About Apple Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Crucial Lessons From Cathie Wood About Apple Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-06-11 19:37 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/apple/news/2-crucial-lessons-from-cathie-wood-about-apple-stock><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Cathie Wood’s ARK Invest is not much of an investor in Apple stock. But the famed fund manager has offered valuable advice about the Cupertino company’s shares that is worth revisiting.\n\nIn doing my ...</p>\n\n<a href=\"https://www.thestreet.com/apple/news/2-crucial-lessons-from-cathie-wood-about-apple-stock\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.thestreet.com/apple/news/2-crucial-lessons-from-cathie-wood-about-apple-stock","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1190309980","content_text":"Cathie Wood’s ARK Invest is not much of an investor in Apple stock. But the famed fund manager has offered valuable advice about the Cupertino company’s shares that is worth revisiting.\n\nIn doing my daily research of Apple stock (AAPL) -Get Report, I stumbled upon a gem from Ark Invest’s CEO, CIO and rockstar money manager Cathie Wood. In January 2016, during aninterviewwith CNBC, she was asked which stock seemed like a better buy at the time: AAPL or AMZN.\nConsidering Apple stock’s loss of 5% in 2015, her response was the following:\n\n “At this moment, […] Apple might be, because […] the thinking there is so short term. […] Apple is going to become a big company, and [the stock] has been depressed recently by channel checks: how iPhone sales will do in the first quarter, or in the second quarter.”\n\nSince this interview, Apple share price climbed a whopping 400%-plus in just over five years.\n#1. Buying quality on weakness\nThe first important lesson from Ms. Wood’s 2016 insight above is that high-quality companies, whose stocks are likely to climb over time, should be bought on weakness. The logic is simple: if the long-term trend is up, buy shares when the market is selling them at a discount.\nI put some numbers around this ideaa couple of months ago. Historically, it has made much more sense to buy AAPL when shares declined from a previous peak.\nThe chart below shows the historical average one-year return in Apple stock under different scenarios. Notice that, the more shares dip, the higher the future returns have been.\nFollowing the same logic, current Apple investors might be encouraged that the stock remains under water: 12% below the January 2021 top of $143. Should AAPL make fresh all-time highs soon, asI recently speculated that it could, returns for the remainder of the year may start to look appealing.\n#2. Filtering out short-term noise\nThe second point made by Cathie Wood is at least as important. In her view, Apple stock was under pressure in 2015 and early 2016 due to short-term concerns over smartphone sales in the following couple of quarters, especially after the blockbuster release of the iPhone 6.\nIn analyzing market movements, I believe it helps to think about the real drivers of share price: buyers and sellers of the stock. Sometimes, people on both sides of the transaction are more concerned about how a stock might perform in the near term, possibly hoping to make a quick buck – and this is just fine.\nIn these cases, long-term buyers are probably better off ignoring “short term noise” about what sales or earnings might look like right around the corner. Better yet, they might want to take advantage of selling pressures created by short-term traders to enter a position at better prices.\nApple might be faced with a similar setup in 2021. The chatter on Wall Street seems torevolve around the company’s follow throughto a successful pandemic year and launch of the first 5G-capable iPhone.\nBut look beyond the next 12 months, and one might find it easier to make a bullish case on Apple stock. The company continues to grow revenues, expand margins, pile on cash, while it has yet to tap intoopportunities in mixed realityandautonomous vehicles.\nTwitter speaks\nBig Tech stocks like Amazon and Apple are a tiny piece of famed investor Cathie Wood’s ARK portfolios. In your view, which of the following FAAMG names would deserve higher allocation in a tech disrupter and innovator ETF? Leave your vote below on our partner's Twitter, @AmazonMaven.\n\nIs the price right?\nLooking at a company’s business fundamentals is only half the work needed to find a good stock. How much one pays to own the shares is a key factor in the success of any investment. This is why valuation analysis is so important.\nAlpha Spread’suser-friendly platform allows you to estimate a stock’s fair value –through valuation multiples, discounted cash flow, and more. I believe that the service is a must for anyone looking to own the right stock at the right price.Check out alphaspread.comand get started with a 7-day free trial.","news_type":1},"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":800415227,"gmtCreate":1627312055269,"gmtModify":1703487458046,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Uhoh","listText":"Uhoh","text":"Uhoh","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/800415227","repostId":"1143156640","repostType":4,"isVote":1,"tweetType":1,"viewCount":331,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":155693485,"gmtCreate":1625408359247,"gmtModify":1703741402582,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Reject!!","listText":"Reject!!","text":"Reject!!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/155693485","repostId":"2148807264","repostType":4,"repost":{"id":"2148807264","pubTimestamp":1625368443,"share":"https://ttm.financial/m/news/2148807264?lang=&edition=fundamental","pubTime":"2021-07-04 11:14","market":"us","language":"en","title":"Dutch Court Rejects Facebook's Offer To Dismiss Privacy Lawsuit In Netherlands","url":"https://stock-news.laohu8.com/highlight/detail?id=2148807264","media":"Benzinga","summary":"On Saturday, an Amsterdam court ruled that the privacy litigation against Facebook Inc. (NASDAQ: FB)","content":"<p><img src=\"https://static.tigerbbs.com/a9c697ef0765f58a6901d25f60c1bf6e\" tg-width=\"600\" tg-height=\"400\" referrerpolicy=\"no-referrer\"></p>\n<p>On Saturday, an&nbsp;Amsterdam court&nbsp;ruled that the privacy litigation against&nbsp;<b><a href=\"https://laohu8.com/S/FB\">Facebook</a> Inc.</b>&nbsp;(NASDAQ: FB) in the Netherlands can proceed. The case will be heard in October, the&nbsp;Verge&nbsp;reported.</p>\n<p>The court rejected Facebook’s offer to have the lawsuit from two non-profit groups thrown out.</p>\n<p>The Amsterdam-based Data Privacy Foundation and Dutch consumer advocacy organization Consumentenbond have filed a lawsuit against Facebook for violating the European Union privacy law.</p>\n<p>According to the lawsuit, Facebook has not provided details about the information it gathers from users. Facebook has also not mentioned what it does with the data; hence, it cannot process it.</p>\n<p>Facebook denies the allegations and claims it respects user privacy and provides people with meaningful control over how their data gets exploited.</p>\n<p>According to the court, “The Data Privacy Foundation may litigate before the Dutch court on behalf of Dutch users of the Facebook service against Facebook about whether Facebook has violated the privacy of its users.”</p>\n<p>European Union law allows for collective redress across several areas, including data protection rights, enabling qualified entities to bring representative actions on behalf of rights holders.</p>\n<p>Facebook claims that the Amsterdam court doesn’t have jurisdiction over its European business, which it argues is subject to Irish law.</p>\n<p><b>Price Action:</b>&nbsp;FB shares closed higher by 0.09% at $354.70 on Friday.</p>\n<p></p>","source":"yahoofinance","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Dutch Court Rejects Facebook's Offer To Dismiss Privacy Lawsuit In Netherlands</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDutch Court Rejects Facebook's Offer To Dismiss Privacy Lawsuit In Netherlands\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-04 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/dutch-court-rejects-facebooks-offer-202803054.html><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>On Saturday, an Amsterdam court ruled that the privacy litigation against Facebook Inc. (NASDAQ: FB) in the Netherlands can proceed. The case will be heard in October, the Verge reported.\nThe court ...</p>\n\n<a href=\"https://finance.yahoo.com/news/dutch-court-rejects-facebooks-offer-202803054.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"QNETCN":"纳斯达克中美互联网老虎指数","03086":"华夏纳指","09086":"华夏纳指-U"},"source_url":"https://finance.yahoo.com/news/dutch-court-rejects-facebooks-offer-202803054.html","is_english":true,"share_image_url":"https://static.laohu8.com/5f26f4a48f9cb3e29be4d71d3ba8c038","article_id":"2148807264","content_text":"On Saturday, an Amsterdam court ruled that the privacy litigation against Facebook Inc. (NASDAQ: FB) in the Netherlands can proceed. The case will be heard in October, the Verge reported.\nThe court rejected Facebook’s offer to have the lawsuit from two non-profit groups thrown out.\nThe Amsterdam-based Data Privacy Foundation and Dutch consumer advocacy organization Consumentenbond have filed a lawsuit against Facebook for violating the European Union privacy law.\nAccording to the lawsuit, Facebook has not provided details about the information it gathers from users. Facebook has also not mentioned what it does with the data; hence, it cannot process it.\nFacebook denies the allegations and claims it respects user privacy and provides people with meaningful control over how their data gets exploited.\nAccording to the court, “The Data Privacy Foundation may litigate before the Dutch court on behalf of Dutch users of the Facebook service against Facebook about whether Facebook has violated the privacy of its users.”\nEuropean Union law allows for collective redress across several areas, including data protection rights, enabling qualified entities to bring representative actions on behalf of rights holders.\nFacebook claims that the Amsterdam court doesn’t have jurisdiction over its European business, which it argues is subject to Irish law.\nPrice Action: FB shares closed higher by 0.09% at $354.70 on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":163,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":184568175,"gmtCreate":1623719021997,"gmtModify":1704209411701,"author":{"id":"3580265488164620","authorId":"3580265488164620","name":"Maximus88","avatar":"https://static.tigerbbs.com/86d19effbbdd9cc5898210cf7c326349","crmLevel":4,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3580265488164620","authorIdStr":"3580265488164620"},"themes":[],"htmlText":"Gogo!","listText":"Gogo!","text":"Gogo!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/184568175","repostId":"1146208169","repostType":4,"isVote":1,"tweetType":1,"viewCount":76,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}